,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,9753,370,IUPHAR/BPS Guide to PHARMACOLOGY,Gallic Acid,5549,gallic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5549,2597,carbonic anhydrase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2597,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),Inhibition,pKi,5.5,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,
1,18274,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T53378,Carbonic anhydrase IV (CA-IV),https://idrblab.net/ttd/data/target/details/T53378,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),Inhibitor,,,,,,,
2,18275,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),Inhibitor,,,,,,,
3,18468,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T31992,Carbonic anhydrase XIV (CA-XIV),https://idrblab.net/ttd/data/target/details/T31992,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606,Homo sapiens (human),Inhibitor,,,,,,,
4,18469,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T06569,Carbonic anhydrase VI (CA-VI),https://idrblab.net/ttd/data/target/details/T06569,P23280,Carbonic anhydrase 6,765.0,CA6,9606,Homo sapiens (human),Inhibitor,,,,,,,
5,18470,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T10965,P-selectin (SELP),https://idrblab.net/ttd/data/target/details/T10965,P16109,P-selectin,6403.0,SELP,9606,Homo sapiens (human),Inhibitor,,,,,,,
6,18471,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606,Homo sapiens (human),Inhibitor,,,,,,,
7,18472,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606,Homo sapiens (human),Inhibitor,,,,,,,
8,18473,370,Therapeutic Target Database (TTD),Gallic Acid,D0Y3TZ,GALLICACID,https://idrblab.net/ttd/data/drug/details/D0Y3TZ,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),Inhibitor,,,,,,,
9,31869,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),1052000,PMID:20486938|DOI:10.1111/j.1747-0285.2010.00965.x,https://www.ncbi.nlm.nih.gov/pubmed/20486938|https://doi.org/10.1111/j.1747-0285.2010.00965.x,20486938,10.1111/j.1747-0285.2010.00965.x,
10,31870,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),758000,PMID:20486938|DOI:10.1111/j.1747-0285.2010.00965.x,https://www.ncbi.nlm.nih.gov/pubmed/20486938|https://doi.org/10.1111/j.1747-0285.2010.00965.x,20486938,10.1111/j.1747-0285.2010.00965.x,
11,31871,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,137392,CIBAR1,https://ctdbase.org/detail.go?type=gene&acc=137392,,,137392.0,CIBAR1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CIBAR1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
12,31872,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1153,CIRBP,https://ctdbase.org/detail.go?type=gene&acc=1153,,,1153.0,CIRBP,9606,Homo sapiens (human),Gallic acid results in increased expression of CIRBP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
13,31873,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1152,CKB,https://ctdbase.org/detail.go?type=gene&acc=1152,,,1152.0,CKB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in increased secretion of [CKM protein binds to CKB protein]],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
14,31874,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1158,CKM,https://ctdbase.org/detail.go?type=gene&acc=1158,,,1158.0,CKM,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in increased secretion of [CKM protein binds to CKB protein]],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
15,31875,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6249,CLIP1,https://ctdbase.org/detail.go?type=gene&acc=6249,,,6249.0,CLIP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CLIP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
16,32072,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1203,CLN5,https://ctdbase.org/detail.go?type=gene&acc=1203,,,1203.0,CLN5,9606,Homo sapiens (human),Gallic acid results in decreased expression of CLN5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
17,32073,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9575,CLOCK,https://ctdbase.org/detail.go?type=gene&acc=9575,,,9575.0,CLOCK,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of CLOCK protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of CLOCK mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
18,32074,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,246175,CNOT6L,https://ctdbase.org/detail.go?type=gene&acc=246175,,,246175.0,CNOT6L,9606,Homo sapiens (human),Gallic acid results in decreased expression of CNOT6L mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
19,32075,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29883,CNOT7,https://ctdbase.org/detail.go?type=gene&acc=29883,,,29883.0,CNOT7,9606,Homo sapiens (human),Gallic acid results in increased expression of CNOT7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
20,32076,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1690,COCH,https://ctdbase.org/detail.go?type=gene&acc=1690,,,1690.0,COCH,9606,Homo sapiens (human),Gallic acid results in increased expression of COCH mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
21,32077,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,9986,Oryctolagus cuniculus (rabbit),Gallic acid results in decreased expression of COL2A1 mRNA,,,PMID:25130855,https://www.ncbi.nlm.nih.gov/pubmed/25130855,25130855,,
22,32078,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,10116,Rattus norvegicus (Norway rat),Gallic acid results in decreased expression of COL2A1 mRNA,,,PMID:26107568,https://www.ncbi.nlm.nih.gov/pubmed/26107568,26107568,,
23,32079,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29099,COMMD9,https://ctdbase.org/detail.go?type=gene&acc=29099,,,29099.0,COMMD9,9606,Homo sapiens (human),Gallic acid results in increased expression of COMMD9 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
24,32080,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,64708,COPS7B,https://ctdbase.org/detail.go?type=gene&acc=64708,,,64708.0,COPS7B,9606,Homo sapiens (human),Gallic acid results in decreased expression of COPS7B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
25,32081,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79934,COQ8B,https://ctdbase.org/detail.go?type=gene&acc=79934,,,79934.0,COQ8B,9606,Homo sapiens (human),Gallic acid results in increased expression of COQ8B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
26,32278,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4513,COX2,https://ctdbase.org/detail.go?type=gene&acc=4513,,,4513.0,COX2,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX2 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX2 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
27,32279,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,35279,COX4,https://ctdbase.org/detail.go?type=gene&acc=35279,,,35279.0,COX4,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX4 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX4 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
28,32280,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116,Rattus norvegicus (Norway rat),Gallic acid results in decreased activity of CYP19A1 protein,,,PMID:18310892,https://www.ncbi.nlm.nih.gov/pubmed/18310892,18310892,,
29,32281,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1345,COX6C,https://ctdbase.org/detail.go?type=gene&acc=1345,,,1345.0,COX6C,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX6C mrna]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX6C mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
30,32282,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79869,CPSF7,https://ctdbase.org/detail.go?type=gene&acc=79869,,,79869.0,CPSF7,9606,Homo sapiens (human),Gallic acid results in increased expression of CPSF7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
31,32283,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of CREB1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of CREB1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of CREB1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
32,32284,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1390,CREM,https://ctdbase.org/detail.go?type=gene&acc=1390,,,1390.0,CREM,9606,Homo sapiens (human),Gallic acid results in increased expression of CREM mrna|gallic acid results in decreased expression of CREM mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
33,32285,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1407,CRY1,https://ctdbase.org/detail.go?type=gene&acc=1407,,,1407.0,CRY1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of CRY1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
34,32483,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1408,CRY2,https://ctdbase.org/detail.go?type=gene&acc=1408,,,1408.0,CRY2,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of CRY2 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
35,32484,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,9606,Homo sapiens (human),Gallic acid results in increased expression of CRYBG2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
36,32485,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,10090,Mus musculus (house mouse),Gallic acid results in increased activity of CS protein,,,PMID:31306686,https://www.ncbi.nlm.nih.gov/pubmed/31306686,31306686,,
37,32486,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51496,CTDSPL2,https://ctdbase.org/detail.go?type=gene&acc=51496,,,51496.0,CTDSPL2,9606,Homo sapiens (human),Gallic acid results in increased expression of CTDSPL2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
38,32487,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CTNND1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
39,32488,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),"Gallic acid inhibits the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of CXCL8 protein]",,,PMID:33130239,https://www.ncbi.nlm.nih.gov/pubmed/33130239,33130239,,
40,32489,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]|gallic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
41,32490,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of CXCR4 mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
42,32491,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51523,CXXC5,https://ctdbase.org/detail.go?type=gene&acc=51523,,,51523.0,CXXC5,9606,Homo sapiens (human),Gallic acid results in decreased expression of CXXC5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
43,32492,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51700,CYB5R2,https://ctdbase.org/detail.go?type=gene&acc=51700,,,51700.0,CYB5R2,9606,Homo sapiens (human),Gallic acid results in increased expression of CYB5R2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
44,32689,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606,Homo sapiens (human),Gallic acid affects the localization of CYCS protein|gallic acid results in increased expression of CYCS protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
45,32690,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1540,CYLD,https://ctdbase.org/detail.go?type=gene&acc=1540,,,1540.0,CYLD,9606,Homo sapiens (human),Gallic acid results in decreased expression of CYLD mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
46,32691,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,57404,CYP20A1,https://ctdbase.org/detail.go?type=gene&acc=57404,,,57404.0,CYP20A1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CYP20A1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
47,32692,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,9606,Homo sapiens (human),Gallic acid results in decreased expression of DAPK1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
48,32693,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,9606,Homo sapiens (human),Gallic acid results in decreased expression of DBN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
49,32694,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26094,DCAF4,https://ctdbase.org/detail.go?type=gene&acc=26094,,,26094.0,DCAF4,9606,Homo sapiens (human),Gallic acid results in decreased expression of DCAF4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
50,32695,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1653,DDX1,https://ctdbase.org/detail.go?type=gene&acc=1653,,,1653.0,DDX1,9606,Homo sapiens (human),Gallic acid results in increased expression of DDX1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
51,32696,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51202,DDX47,https://ctdbase.org/detail.go?type=gene&acc=51202,,,51202.0,DDX47,9606,Homo sapiens (human),Gallic acid results in decreased expression of DDX47 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
52,32697,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79009,DDX50,https://ctdbase.org/detail.go?type=gene&acc=79009,,,79009.0,DDX50,9606,Homo sapiens (human),Gallic acid results in decreased expression of DDX50 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
53,32698,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9681,DEPDC5,https://ctdbase.org/detail.go?type=gene&acc=9681,,,9681.0,DEPDC5,9606,Homo sapiens (human),Gallic acid results in decreased expression of DEPDC5 mrna|gallic acid results in increased expression of DEPDC5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
54,32699,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54487,DGCR8,https://ctdbase.org/detail.go?type=gene&acc=54487,,,54487.0,DGCR8,9606,Homo sapiens (human),Gallic acid results in decreased expression of DGCR8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
55,32893,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,80017,DGLUCY,https://ctdbase.org/detail.go?type=gene&acc=80017,,,80017.0,DGLUCY,9606,Homo sapiens (human),Gallic acid results in decreased expression of DGLUCY mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
56,32894,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1718,DHCR24,https://ctdbase.org/detail.go?type=gene&acc=1718,,,1718.0,DHCR24,9606,Homo sapiens (human),Gallic acid results in decreased expression of DHCR24 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
57,32895,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1729,DIAPH1,https://ctdbase.org/detail.go?type=gene&acc=1729,,,1729.0,DIAPH1,9606,Homo sapiens (human),Gallic acid results in increased expression of DIAPH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
58,32896,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1730,DIAPH2,https://ctdbase.org/detail.go?type=gene&acc=1730,,,1730.0,DIAPH2,9606,Homo sapiens (human),Gallic acid results in decreased expression of DIAPH2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
59,32897,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22982,DIP2C,https://ctdbase.org/detail.go?type=gene&acc=22982,,,22982.0,DIP2C,9606,Homo sapiens (human),Gallic acid results in decreased expression of DIP2C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
60,32898,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,9606,Homo sapiens (human),Gallic acid results in decreased expression of DNAJB6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
61,32899,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1759,DNM1,https://ctdbase.org/detail.go?type=gene&acc=1759,,,1759.0,DNM1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
62,32900,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1759,DNM1,https://ctdbase.org/detail.go?type=gene&acc=1759,,,1759.0,DNM1,9606,Homo sapiens (human),Gallic acid results in decreased expression of DNM1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
63,32901,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1L protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
64,32902,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26052,DNM3,https://ctdbase.org/detail.go?type=gene&acc=26052,,,26052.0,DNM3,9606,Homo sapiens (human),Gallic acid results in increased expression of DNM3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
65,33088,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,85440,DOCK7,https://ctdbase.org/detail.go?type=gene&acc=85440,,,85440.0,DOCK7,9606,Homo sapiens (human),Gallic acid results in decreased expression of DOCK7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
66,33089,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,91039,DPP9,https://ctdbase.org/detail.go?type=gene&acc=91039,,,91039.0,DPP9,9606,Homo sapiens (human),Gallic acid results in increased expression of DPP9 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
67,33090,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,667,DST,https://ctdbase.org/detail.go?type=gene&acc=667,,,667.0,DST,9606,Homo sapiens (human),Gallic acid results in decreased expression of DST mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
68,33091,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,144455,E2F7,https://ctdbase.org/detail.go?type=gene&acc=144455,,,144455.0,E2F7,9606,Homo sapiens (human),Gallic acid results in decreased expression of E2F7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
69,33092,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84650,EBPL,https://ctdbase.org/detail.go?type=gene&acc=84650,,,84650.0,EBPL,9606,Homo sapiens (human),Gallic acid results in decreased expression of EBPL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
70,33093,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1936,EEF1D,https://ctdbase.org/detail.go?type=gene&acc=1936,,,1936.0,EEF1D,9606,Homo sapiens (human),Gallic acid results in increased expression of EEF1D mrna|gallic acid results in decreased expression of EEF1D mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
71,33094,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606,Homo sapiens (human),[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mrna]|ep300 protein inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased acetylation of and results in increased expression of EP300 protein]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]|map2k1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]|gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]|map2k1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
72,33095,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]]|gallic acid inhibits the reaction [EGF protein results in increased activity of SRC protein]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]|gallic acid inhibits the reaction [EGF protein results in increased expression of and results in increased secretion of MMP9 protein]|src protein modified form affects the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
73,33294,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606,Homo sapiens (human),Gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]|gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mrna],,,PMID:27087131|PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27087131|https://www.ncbi.nlm.nih.gov/pubmed/27634460,27087131|27634460,,
74,33295,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
75,33296,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),Gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein],,,PMID:27087131|PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27087131|https://www.ncbi.nlm.nih.gov/pubmed/27634460,27087131|27634460,,
76,33297,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),SRC protein modified form affects the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
77,33298,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7260,EIPR1,https://ctdbase.org/detail.go?type=gene&acc=7260,,,7260.0,EIPR1,9606,Homo sapiens (human),Gallic acid results in decreased expression of EIPR1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
78,33299,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,222223,ELAPOR2,https://ctdbase.org/detail.go?type=gene&acc=222223,,,222223.0,ELAPOR2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ELAPOR2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
79,33300,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84173,ELMOD3,https://ctdbase.org/detail.go?type=gene&acc=84173,,,84173.0,ELMOD3,9606,Homo sapiens (human),Gallic acid results in decreased expression of ELMOD3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
80,33301,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,56946,EMSY,https://ctdbase.org/detail.go?type=gene&acc=56946,,,56946.0,EMSY,9606,Homo sapiens (human),Gallic acid results in decreased expression of EMSY mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
81,33302,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2026,ENO2,https://ctdbase.org/detail.go?type=gene&acc=2026,,,2026.0,ENO2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ENO2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
82,33303,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,58478,ENOPH1,https://ctdbase.org/detail.go?type=gene&acc=58478,,,58478.0,ENOPH1,9606,Homo sapiens (human),Gallic acid results in increased expression of ENOPH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
83,33509,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606,Homo sapiens (human),EP300 protein inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased acetylation of and results in increased expression of EP300 protein]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
84,33510,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2035,EPB41,https://ctdbase.org/detail.go?type=gene&acc=2035,,,2035.0,EPB41,9606,Homo sapiens (human),Gallic acid results in increased expression of EPB41 mrna|gallic acid results in decreased expression of EPB41 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
85,33511,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51614,ERGIC3,https://ctdbase.org/detail.go?type=gene&acc=51614,,,51614.0,ERGIC3,9606,Homo sapiens (human),Gallic acid results in increased expression of ERGIC3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
86,33512,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,9606,Homo sapiens (human),Gallic acid results in increased expression of FAM110A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
87,33513,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,220965,FAM13C,https://ctdbase.org/detail.go?type=gene&acc=220965,,,220965.0,FAM13C,9606,Homo sapiens (human),Gallic acid results in decreased expression of FAM13C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
88,33514,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,57697,FANCM,https://ctdbase.org/detail.go?type=gene&acc=57697,,,57697.0,FANCM,9606,Homo sapiens (human),Gallic acid results in increased expression of FANCM mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
89,33515,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606,Homo sapiens (human),Gallic acid results in increased expression of FASLG protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
90,33516,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23291,FBXW11,https://ctdbase.org/detail.go?type=gene&acc=23291,,,23291.0,FBXW11,9606,Homo sapiens (human),Gallic acid results in decreased expression of FBXW11 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
91,33517,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51024,FIS1,https://ctdbase.org/detail.go?type=gene&acc=51024,,,51024.0,FIS1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of FIS1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of FIS1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
92,33518,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,60681,FKBP10,https://ctdbase.org/detail.go?type=gene&acc=60681,,,60681.0,FKBP10,9606,Homo sapiens (human),Gallic acid results in increased expression of FKBP10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
93,33715,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79147,FKRP,https://ctdbase.org/detail.go?type=gene&acc=79147,,,79147.0,FKRP,9606,Homo sapiens (human),Gallic acid results in increased expression of FKRP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
94,33716,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23767,FLRT3,https://ctdbase.org/detail.go?type=gene&acc=23767,,,23767.0,FLRT3,9606,Homo sapiens (human),Gallic acid results in increased expression of FLRT3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
95,33717,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of FN1 protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
96,33718,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23048,FNBP1,https://ctdbase.org/detail.go?type=gene&acc=23048,,,23048.0,FNBP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of FNBP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
97,33719,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2348,FOLR1,https://ctdbase.org/detail.go?type=gene&acc=2348,,,2348.0,FOLR1,9606,Homo sapiens (human),Gallic acid results in increased expression of FOLR1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
98,33720,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [doxorubicin results in decreased phosphorylation of FOXO3 protein],,,PMID:36572231,https://www.ncbi.nlm.nih.gov/pubmed/36572231,36572231,,
99,33721,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [diethylhexyl phthalate results in increased expression of FSHB protein],,,PMID:35196152,https://www.ncbi.nlm.nih.gov/pubmed/35196152,35196152,,
100,33722,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in decreased expression of FSHB protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
101,33723,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in decreased activity of G6PD protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
102,33724,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2551,GABPA,https://ctdbase.org/detail.go?type=gene&acc=2551,,,2551.0,GABPA,9606,Homo sapiens (human),Gallic acid affects the localization of and results in increased activity of GABPA protein|pyrazolanthrone inhibits the reaction [gallic acid results in increased expression of GABPA protein]|sb 203580 inhibits the reaction [gallic acid results in increased expression of GABPA protein],,,PMID:16308312,https://www.ncbi.nlm.nih.gov/pubmed/16308312,16308312,,
103,33918,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2618,GART,https://ctdbase.org/detail.go?type=gene&acc=2618,,,2618.0,GART,9606,Homo sapiens (human),Gallic acid results in decreased expression of GART mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
104,33919,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26301,GBGT1,https://ctdbase.org/detail.go?type=gene&acc=26301,,,26301.0,GBGT1,9606,Homo sapiens (human),Gallic acid results in increased expression of GBGT1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
105,33920,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79760,GEMIN7,https://ctdbase.org/detail.go?type=gene&acc=79760,,,79760.0,GEMIN7,9606,Homo sapiens (human),Gallic acid results in decreased expression of GEMIN7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
106,33921,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,81577,GFOD2,https://ctdbase.org/detail.go?type=gene&acc=81577,,,81577.0,GFOD2,9606,Homo sapiens (human),Gallic acid results in decreased expression of GFOD2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
107,33922,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26088,GGA1,https://ctdbase.org/detail.go?type=gene&acc=26088,,,26088.0,GGA1,9606,Homo sapiens (human),Gallic acid results in decreased expression of GGA1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
108,33923,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26058,GIGYF2,https://ctdbase.org/detail.go?type=gene&acc=26058,,,26058.0,GIGYF2,9606,Homo sapiens (human),Gallic acid results in decreased expression of GIGYF2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
109,33924,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,126326,GIPC3,https://ctdbase.org/detail.go?type=gene&acc=126326,,,126326.0,GIPC3,9606,Homo sapiens (human),Gallic acid results in decreased expression of GIPC3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
110,33925,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10052,GJC1,https://ctdbase.org/detail.go?type=gene&acc=10052,,,10052.0,GJC1,9606,Homo sapiens (human),Gallic acid results in increased expression of GJC1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
111,33926,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2736,GLI2,https://ctdbase.org/detail.go?type=gene&acc=2736,,,2736.0,GLI2,9606,Homo sapiens (human),Gallic acid results in decreased expression of GLI2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
112,33927,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2774,GNAL,https://ctdbase.org/detail.go?type=gene&acc=2774,,,2774.0,GNAL,9606,Homo sapiens (human),Gallic acid results in increased expression of GNAL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
113,33928,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2784,GNB3,https://ctdbase.org/detail.go?type=gene&acc=2784,,,2784.0,GNB3,9606,Homo sapiens (human),Gallic acid results in decreased expression of GNB3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
114,34121,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10020,GNE,https://ctdbase.org/detail.go?type=gene&acc=10020,,,10020.0,GNE,9606,Homo sapiens (human),Gallic acid results in decreased expression of GNE mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
115,34122,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2802,GOLGA3,https://ctdbase.org/detail.go?type=gene&acc=2802,,,2802.0,GOLGA3,9606,Homo sapiens (human),Gallic acid results in increased expression of GOLGA3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
116,34123,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,9606,Homo sapiens (human),Gallic acid inhibits the reaction [ethanol results in increased activity of GPT protein]|nfe2l2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased activity of GPT protein]],,,PMID:30853489,https://www.ncbi.nlm.nih.gov/pubmed/30853489,30853489,,
117,34124,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),[gallic acid co-treated with dietary fats co-treated with dust] affects the expression of GPT protein,,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
118,34125,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [dust results in increased expression of GPT protein],,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
119,34126,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2885,GRB2,https://ctdbase.org/detail.go?type=gene&acc=2885,,,2885.0,GRB2,9606,Homo sapiens (human),Gallic acid results in decreased expression of GRB2 protein,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
120,34127,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in decreased activity of GSR protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
121,34128,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in decreased expression of GSR protein],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
122,34129,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased activity of GSR protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
123,34130,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,85865,GTPBP10,https://ctdbase.org/detail.go?type=gene&acc=85865,,,85865.0,GTPBP10,9606,Homo sapiens (human),Gallic acid results in decreased expression of GTPBP10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
124,34322,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2997,GYS1,https://ctdbase.org/detail.go?type=gene&acc=2997,,,2997.0,GYS1,9606,Homo sapiens (human),Gallic acid results in decreased expression of GYS1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
125,34323,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,440689,H2BC18,https://ctdbase.org/detail.go?type=gene&acc=440689,,,440689.0,H2BC18,9606,Homo sapiens (human),Gallic acid results in decreased expression of H2BC18 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
126,34324,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3032,HADHB,https://ctdbase.org/detail.go?type=gene&acc=3032,,,3032.0,HADHB,9606,Homo sapiens (human),Gallic acid results in increased expression of HADHB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
127,34325,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26959,HBP1,https://ctdbase.org/detail.go?type=gene&acc=26959,,,26959.0,HBP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of HBP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
128,34326,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9031,Gallus gallus (chicken),Gallic acid results in increased expression of HIF1A mRNA,,,PMID:23406025,https://www.ncbi.nlm.nih.gov/pubmed/23406025,23406025,,
129,34327,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Gallic acid results in decreased expression of HIF1A mrna|akt1 protein inhibits the reaction [gallic acid results in decreased expression of HIF1A mrna]|gallic acid results in decreased expression of HIF1A protein|hif1a protein inhibits the reaction [gallic acid results in decreased expression of VEGFA mrna],,,PMID:26530725,https://www.ncbi.nlm.nih.gov/pubmed/26530725,26530725,,
130,34328,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51501,HIKESHI,https://ctdbase.org/detail.go?type=gene&acc=51501,,,51501.0,HIKESHI,9606,Homo sapiens (human),Gallic acid results in increased expression of HIKESHI mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
131,34329,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3141,HLCS,https://ctdbase.org/detail.go?type=gene&acc=3141,,,3141.0,HLCS,9606,Homo sapiens (human),Gallic acid results in decreased activity of HLCS protein,,,PMID:26303405,https://www.ncbi.nlm.nih.gov/pubmed/26303405,26303405,,
132,34330,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3145,HMBS,https://ctdbase.org/detail.go?type=gene&acc=3145,,,3145.0,HMBS,9606,Homo sapiens (human),Gallic acid results in decreased expression of HMBS mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
133,34331,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606,Homo sapiens (human),NFE2L2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased secretion of HMGB1 protein]]|gallic acid inhibits the reaction [ethanol results in increased secretion of HMGB1 protein],,,PMID:30853489,https://www.ncbi.nlm.nih.gov/pubmed/30853489,30853489,,
134,34529,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606,Homo sapiens (human),Gallic acid results in increased expression of HMGB1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
135,34530,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of HMOX1 protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of HMOX1 protein,,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
136,34531,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of HMOX1 mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
137,34532,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased expression of and results in increased activity of HMOX1 protein],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
138,34533,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),[gallic acid co-treated with dust] results in increased expression of HMOX1 mRNA,,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
139,34534,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3163,HMOX2,https://ctdbase.org/detail.go?type=gene&acc=3163,,,3163.0,HMOX2,9606,Homo sapiens (human),Gallic acid results in increased expression of HMOX2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
140,34535,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3226,HOXC10,https://ctdbase.org/detail.go?type=gene&acc=3226,,,3226.0,HOXC10,9606,Homo sapiens (human),Gallic acid results in decreased expression of HOXC10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
141,34536,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3269,HRH1,https://ctdbase.org/detail.go?type=gene&acc=3269,,,3269.0,HRH1,9606,Homo sapiens (human),Gallic acid results in decreased expression of HRH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
142,34537,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3295,HSD17B4,https://ctdbase.org/detail.go?type=gene&acc=3295,,,3295.0,HSD17B4,9606,Homo sapiens (human),Gallic acid results in decreased expression of HSD17B4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
143,34538,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,9606,Homo sapiens (human),Gallic acid results in decreased expression of HSP90AA1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
144,34736,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,9606,Homo sapiens (human),Gallic acid results in decreased expression of HSPA8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
145,34737,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3064,HTT,https://ctdbase.org/detail.go?type=gene&acc=3064,,,3064.0,HTT,9606,Homo sapiens (human),Gallic acid results in decreased expression of HTT mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
146,34738,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84668,HYCC1,https://ctdbase.org/detail.go?type=gene&acc=84668,,,84668.0,HYCC1,9606,Homo sapiens (human),Gallic acid results in decreased expression of HYCC1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
147,34739,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,25998,IBTK,https://ctdbase.org/detail.go?type=gene&acc=25998,,,25998.0,IBTK,9606,Homo sapiens (human),Gallic acid results in increased expression of IBTK mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
148,34740,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased expression of ICAM1 mrna],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
149,34741,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23308,ICOSLG,https://ctdbase.org/detail.go?type=gene&acc=23308,,,23308.0,ICOSLG,9606,Homo sapiens (human),Gallic acid results in increased expression of ICOSLG mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
150,34742,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),"Gallic acid inhibits the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of CXCL8 protein]|gallic acid inhibits the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]|[gallic acid co-treated with butyric acid co-treated with verbascose] affects the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]",,,PMID:33130239,https://www.ncbi.nlm.nih.gov/pubmed/33130239,33130239,,
151,34743,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3459,IFNGR1,https://ctdbase.org/detail.go?type=gene&acc=3459,,,3459.0,IFNGR1,9606,Homo sapiens (human),Gallic acid results in decreased expression of IFNGR1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
152,34744,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7866,IFRD2,https://ctdbase.org/detail.go?type=gene&acc=7866,,,7866.0,IFRD2,9606,Homo sapiens (human),Gallic acid results in increased expression of IFRD2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
153,34745,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11020,IFT27,https://ctdbase.org/detail.go?type=gene&acc=11020,,,11020.0,IFT27,9606,Homo sapiens (human),Gallic acid results in increased expression of IFT27 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
154,34941,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,9606,Homo sapiens (human),Gallic acid results in increased expression of IGF1R mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
155,34942,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
156,34943,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22807,IKZF2,https://ctdbase.org/detail.go?type=gene&acc=22807,,,22807.0,IKZF2,9606,Homo sapiens (human),Gallic acid results in increased expression of IKZF2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
157,34944,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84818,IL17RC,https://ctdbase.org/detail.go?type=gene&acc=84818,,,84818.0,IL17RC,9606,Homo sapiens (human),Gallic acid results in decreased expression of IL17RC mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
158,34945,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),"Gallic acid inhibits the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]|[gallic acid co-treated with butyric acid co-treated with verbascose] affects the reaction [[lipopolysaccharide, escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]",,,PMID:33130239,https://www.ncbi.nlm.nih.gov/pubmed/33130239,33130239,,
159,34946,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [diethylhexyl phthalate results in increased expression of IL1B protein],,,PMID:35196152,https://www.ncbi.nlm.nih.gov/pubmed/35196152,35196152,,
160,34947,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased expression of IL1B mrna],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
161,34948,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [cobaltous chloride results in increased expression of IL1B protein],,,PMID:31362009,https://www.ncbi.nlm.nih.gov/pubmed/31362009,31362009,,
162,34949,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of IL1B protein]|gallic acid inhibits the reaction [glucose results in increased secretion of IL1B protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
163,34950,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [quinolinic acid results in increased expression of IL1B protein],,,PMID:29981346,https://www.ncbi.nlm.nih.gov/pubmed/29981346,29981346,,
164,35154,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Gallic acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein],,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
165,35155,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606,Homo sapiens (human),Gallic acid results in decreased expression of IL1R1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
166,35156,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9031,Gallus gallus (chicken),Gallic acid results in decreased expression of IL6 protein,,,PMID:23406025,https://www.ncbi.nlm.nih.gov/pubmed/23406025,23406025,,
167,35157,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of IL6 mrna]|gallic acid inhibits the reaction [TNF protein results in increased secretion of IL6 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
168,35158,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [acrylamide results in increased secretion of IL6 protein],,,PMID:37037409,https://www.ncbi.nlm.nih.gov/pubmed/37037409,37037409,,
169,35159,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of IL6 mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
170,35160,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [glucose results in increased secretion of IL6 protein]|gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of IL6 protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
171,35161,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [quinolinic acid results in increased expression of IL6 protein],,,PMID:29981346,https://www.ncbi.nlm.nih.gov/pubmed/29981346,29981346,,
172,35162,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3614,IMPDH1,https://ctdbase.org/detail.go?type=gene&acc=3614,,,3614.0,IMPDH1,9606,Homo sapiens (human),Gallic acid results in decreased expression of IMPDH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
173,35163,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),Gallic acid results in increased secretion of INS1 protein,,,PMID:21078310,https://www.ncbi.nlm.nih.gov/pubmed/21078310,21078310,,
174,35364,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,81556,INTS14,https://ctdbase.org/detail.go?type=gene&acc=81556,,,81556.0,INTS14,9606,Homo sapiens (human),Gallic acid results in decreased expression of INTS14 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
175,35365,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51447,IP6K2,https://ctdbase.org/detail.go?type=gene&acc=51447,,,51447.0,IP6K2,9606,Homo sapiens (human),Gallic acid results in increased expression of IP6K2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
176,35366,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9798,IST1,https://ctdbase.org/detail.go?type=gene&acc=9798,,,9798.0,IST1,9606,Homo sapiens (human),Gallic acid results in increased expression of IST1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
177,35367,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3684,ITGAM,https://ctdbase.org/detail.go?type=gene&acc=3684,,,3684.0,ITGAM,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [acrylamide results in increased expression of ITGAM protein],,,PMID:37037409,https://www.ncbi.nlm.nih.gov/pubmed/37037409,37037409,,
178,35368,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,81618,ITM2C,https://ctdbase.org/detail.go?type=gene&acc=81618,,,81618.0,ITM2C,9606,Homo sapiens (human),Gallic acid results in decreased expression of ITM2C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
179,35369,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,65094,JMJD4,https://ctdbase.org/detail.go?type=gene&acc=65094,,,65094.0,JMJD4,9606,Homo sapiens (human),Gallic acid results in increased expression of JMJD4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
180,35370,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606,Homo sapiens (human),[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]|map2k1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
181,35371,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606,Homo sapiens (human),Gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein],,,PMID:27087131|PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27087131|https://www.ncbi.nlm.nih.gov/pubmed/27634460,27087131|27634460,,
182,35372,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
183,35373,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7994,KAT6A,https://ctdbase.org/detail.go?type=gene&acc=7994,,,7994.0,KAT6A,9606,Homo sapiens (human),Gallic acid results in decreased expression of KAT6A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
184,35579,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23522,KAT6B,https://ctdbase.org/detail.go?type=gene&acc=23522,,,23522.0,KAT6B,9606,Homo sapiens (human),Gallic acid results in decreased expression of KAT6B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
185,35580,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55818,KDM3A,https://ctdbase.org/detail.go?type=gene&acc=55818,,,55818.0,KDM3A,9606,Homo sapiens (human),Gallic acid results in increased expression of KDM3A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
186,35581,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,2531,KDSR,https://ctdbase.org/detail.go?type=gene&acc=2531,,,2531.0,KDSR,9606,Homo sapiens (human),Gallic acid results in decreased expression of KDSR mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
187,35582,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9851,KIAA0753,https://ctdbase.org/detail.go?type=gene&acc=9851,,,9851.0,KIAA0753,9606,Homo sapiens (human),Gallic acid results in decreased expression of KIAA0753 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
188,35583,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9493,KIF23,https://ctdbase.org/detail.go?type=gene&acc=9493,,,9493.0,KIF23,9606,Homo sapiens (human),Gallic acid results in increased expression of KIF23 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
189,35584,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,90293,KLHL13,https://ctdbase.org/detail.go?type=gene&acc=90293,,,90293.0,KLHL13,9606,Homo sapiens (human),Gallic acid results in increased expression of KLHL13 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
190,35585,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,58508,KMT2C,https://ctdbase.org/detail.go?type=gene&acc=58508,,,58508.0,KMT2C,9606,Homo sapiens (human),Gallic acid results in decreased expression of KMT2C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
191,35586,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3837,KPNB1,https://ctdbase.org/detail.go?type=gene&acc=3837,,,3837.0,KPNB1,9606,Homo sapiens (human),Gallic acid results in increased expression of KPNB1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
192,35587,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,347404,LANCL3,https://ctdbase.org/detail.go?type=gene&acc=347404,,,347404.0,LANCL3,9606,Homo sapiens (human),Gallic acid results in decreased expression of LANCL3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
193,35588,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,253558,LCLAT1,https://ctdbase.org/detail.go?type=gene&acc=253558,,,253558.0,LCLAT1,9606,Homo sapiens (human),Gallic acid results in decreased expression of LCLAT1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
194,35589,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,60526,LDAH,https://ctdbase.org/detail.go?type=gene&acc=60526,,,60526.0,LDAH,9606,Homo sapiens (human),Gallic acid results in increased expression of LDAH mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
195,35788,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in increased secretion of LDHA protein],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
196,35789,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in increased secretion of LDHB protein],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
197,35790,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),Gallic acid results in increased expression of LDLR mRNA,,,PMID:12612140,https://www.ncbi.nlm.nih.gov/pubmed/12612140,12612140,,
198,35791,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [diethylhexyl phthalate results in increased expression of LHB protein],,,PMID:35196152,https://www.ncbi.nlm.nih.gov/pubmed/35196152,35196152,,
199,35792,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in decreased expression of LHB protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
200,35793,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3981,LIG4,https://ctdbase.org/detail.go?type=gene&acc=3981,,,3981.0,LIG4,9606,Homo sapiens (human),Gallic acid results in decreased expression of LIG4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
201,35794,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51474,LIMA1,https://ctdbase.org/detail.go?type=gene&acc=51474,,,51474.0,LIMA1,9606,Homo sapiens (human),Gallic acid results in decreased expression of LIMA1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
202,35795,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51601,LIPT1,https://ctdbase.org/detail.go?type=gene&acc=51601,,,51601.0,LIPT1,9606,Homo sapiens (human),Gallic acid results in increased expression of LIPT1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
203,35796,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4026,LPP,https://ctdbase.org/detail.go?type=gene&acc=4026,,,4026.0,LPP,9606,Homo sapiens (human),Gallic acid results in decreased expression of LPP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
204,35797,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,114659,LRRC37B,https://ctdbase.org/detail.go?type=gene&acc=114659,,,114659.0,LRRC37B,9606,Homo sapiens (human),Gallic acid results in increased expression of LRRC37B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
205,35798,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4074,M6PR,https://ctdbase.org/detail.go?type=gene&acc=4074,,,4074.0,M6PR,9606,Homo sapiens (human),Gallic acid results in increased expression of M6PR mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
206,35813,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5167,Plasminogen activator inhibitor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5167,P05121,Plasminogen activator inhibitor 1,5054.0,SERPINE1,9606,Homo sapiens (human),,IC50 (nM),6.6e+3,PMID:20061381|DOI:10.1074/jbc.M109.067967,https://www.ncbi.nlm.nih.gov/pubmed/20061381|https://doi.org/10.1074/jbc.M109.067967,20061381,10.1074/jbc.M109.067967,
207,35814,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5146,"Alpha-(1,3)-fucosyltransferase 7",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5146,Q11130,"Alpha-(1,3)-fucosyltransferase 7",2529.0,FUT7,9606,Homo sapiens (human),,IC50 (nM),60,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
208,35815,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5146,"Alpha-(1,3)-fucosyltransferase 7",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5146,Q11130,"Alpha-(1,3)-fucosyltransferase 7",2529.0,FUT7,9606,Homo sapiens (human),,IC50 (nM),8000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
209,35816,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5147,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5147,P51993,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6,2528.0,FUT6,9606,Homo sapiens (human),,IC50 (nM),14000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
210,35817,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5148,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5148,Q11201,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",6482.0,ST3GAL1,9606,Homo sapiens (human),,IC50 (nM),19000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
211,35993,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4105,MAGEA6,https://ctdbase.org/detail.go?type=gene&acc=4105,,,4105.0,MAGEA6,9606,Homo sapiens (human),Gallic acid results in increased expression of MAGEA6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
212,35994,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K1 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
213,35995,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606,Homo sapiens (human),MAP2K1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|map2k1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
214,35996,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
215,35997,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6416,MAP2K4,https://ctdbase.org/detail.go?type=gene&acc=6416,,,6416.0,MAP2K4,9606,Homo sapiens (human),Gallic acid results in increased expression of MAP2K4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
216,35998,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9064,MAP3K6,https://ctdbase.org/detail.go?type=gene&acc=9064,,,9064.0,MAP3K6,9606,Homo sapiens (human),Gallic acid results in increased expression of MAP3K6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
217,35999,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9448,MAP4K4,https://ctdbase.org/detail.go?type=gene&acc=9448,,,9448.0,MAP4K4,9606,Homo sapiens (human),Gallic acid results in decreased expression of MAP4K4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
218,36000,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),SRC protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
219,36001,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),Gallic acid results in decreased expression of MAPK1 protein modified form,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
220,36013,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,110,Disintegrin and metalloproteinase domain-containing protein 17,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=110,P78536,Disintegrin and metalloproteinase domain-containing protein 17,6868.0,ADAM17,9606,Homo sapiens (human),,IC50 (nM),>200000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
221,36014,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,112,72 kDa type IV collagenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=112,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606,Homo sapiens (human),,IC50 (nM),>200000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
222,36015,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,6149,Matrilysin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6149,P09237,Matrilysin,4316.0,MMP7,9606,Homo sapiens (human),,IC50 (nM),>200000,PMID:15081893|DOI:10.1016/j.abb.2004.02.039,https://www.ncbi.nlm.nih.gov/pubmed/15081893|https://doi.org/10.1016/j.abb.2004.02.039,15081893,10.1016/j.abb.2004.02.039,
223,36194,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased phosphorylation of MAPK1 protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
224,36195,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),SRC protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
225,36196,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),Gallic acid results in decreased expression of MAPK3 protein modified form,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
226,36197,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased phosphorylation of MAPK3 protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
227,36198,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK8 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
228,36199,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
229,36200,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9782,MATR3,https://ctdbase.org/detail.go?type=gene&acc=9782,,,9782.0,MATR3,9606,Homo sapiens (human),Gallic acid results in decreased expression of MATR3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
230,36201,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4151,MB,https://ctdbase.org/detail.go?type=gene&acc=4151,,,4151.0,MB,9606,Homo sapiens (human),Gallic acid results in decreased expression of MB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
231,36202,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4152,MBD1,https://ctdbase.org/detail.go?type=gene&acc=4152,,,4152.0,MBD1,9606,Homo sapiens (human),Gallic acid results in decreased expression of MBD1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
232,36203,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4200,ME2,https://ctdbase.org/detail.go?type=gene&acc=4200,,,4200.0,ME2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ME2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
233,36405,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,81857,MED25,https://ctdbase.org/detail.go?type=gene&acc=81857,,,81857.0,MED25,9606,Homo sapiens (human),Gallic acid results in decreased expression of MED25 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
234,36406,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1954,MEGF8,https://ctdbase.org/detail.go?type=gene&acc=1954,,,1954.0,MEGF8,9606,Homo sapiens (human),Gallic acid results in increased expression of MEGF8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
235,36407,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,56917,MEIS3,https://ctdbase.org/detail.go?type=gene&acc=56917,,,56917.0,MEIS3,9606,Homo sapiens (human),Gallic acid results in increased expression of MEIS3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
236,36408,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4233,MET,https://ctdbase.org/detail.go?type=gene&acc=4233,,,4233.0,MET,9606,Homo sapiens (human),Gallic acid results in decreased expression of MET mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
237,36409,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79828,METTL8,https://ctdbase.org/detail.go?type=gene&acc=79828,,,79828.0,METTL8,9606,Homo sapiens (human),Gallic acid results in increased expression of METTL8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
238,36410,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55669,MFN1,https://ctdbase.org/detail.go?type=gene&acc=55669,,,55669.0,MFN1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
239,36411,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606,Homo sapiens (human),Gallic acid results in decreased expression of MGMT mRNA,,,PMID:21887735,https://www.ncbi.nlm.nih.gov/pubmed/21887735,21887735,,
240,36412,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116,Rattus norvegicus (Norway rat),"1,1-diphenyl-2-picrylhydrazyl inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|cat protein inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|dithiothreitol inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|sodium arsenite inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|ferric chloride inhibits the reaction [gallic acid results in increased activity of MGST1 protein]",,,PMID:16125204,https://www.ncbi.nlm.nih.gov/pubmed/16125204,16125204,,
241,36413,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,9606,Homo sapiens (human),Gallic acid results in decreased expression of PMP22 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
242,36414,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116,Rattus norvegicus (Norway rat),Triethylenediamine inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|cyclosporine inhibits the reaction [gallic acid results in increased activity of MGST1 protein]|gallic acid results in increased oxidation of and results in increased activity of MGST1 protein|hemin inhibits the reaction [gallic acid results in increased activity of MGST1 protein],,,PMID:19111564,https://www.ncbi.nlm.nih.gov/pubmed/19111564,19111564,,
243,36613,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116,Rattus norvegicus (Norway rat),Gallic acid results in increased activity of MGST1 protein,,,PMID:16125204|PMID:19111564,https://www.ncbi.nlm.nih.gov/pubmed/16125204|https://www.ncbi.nlm.nih.gov/pubmed/19111564,16125204|19111564,,
244,36614,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406906,MIR122,https://ctdbase.org/detail.go?type=gene&acc=406906,,,406906.0,MIR122,9606,Homo sapiens (human),Gallic acid results in decreased expression of MIR122 mRNA,,,PMID:24165878,https://www.ncbi.nlm.nih.gov/pubmed/24165878,24165878,,
245,36615,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406906,MIR122,https://ctdbase.org/detail.go?type=gene&acc=406906,,,406906.0,MIR122,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of MIR122 mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
246,36616,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406906,MIR122,https://ctdbase.org/detail.go?type=gene&acc=406906,,,406906.0,MIR122,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [dust results in increased expression of MIR122 mrna],,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
247,36617,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406983,MIR200A,https://ctdbase.org/detail.go?type=gene&acc=406983,,,406983.0,MIR200A,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in decreased expression of MIR200A mrna],,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
248,36618,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406991,MIR21,https://ctdbase.org/detail.go?type=gene&acc=406991,,,406991.0,MIR21,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in increased expression of MIR21 mrna]|gallic acid results in increased expression of MIR21 mRNA,,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
249,36619,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,407029,MIR30A,https://ctdbase.org/detail.go?type=gene&acc=407029,,,407029.0,MIR30A,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in decreased expression of MIR30A mrna],,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
250,36620,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,407040,MIR34A,https://ctdbase.org/detail.go?type=gene&acc=407040,,,407040.0,MIR34A,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of MIR34A mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
251,36621,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,407040,MIR34A,https://ctdbase.org/detail.go?type=gene&acc=407040,,,407040.0,MIR34A,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [dust results in increased expression of MIR34A mrna],,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
252,36622,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),Gallic acid results in decreased activity of MMP2 protein|gallic acid results in decreased expression of MMP2 mRNA,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
253,36823,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),Gallic acid results in decreased expression of MMP2 protein,,,PMID:22387266|PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/22387266|https://www.ncbi.nlm.nih.gov/pubmed/23153558,22387266|23153558,,
254,36824,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),RHOB mutant form inhibits the reaction [gallic acid results in decreased expression of MMP2 protein],,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
255,36825,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP2 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP2 protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
256,36826,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606,Homo sapiens (human),Gallic acid inhibits the reaction [tretinoin results in increased expression of MMP7 mrna]|gallic acid inhibits the reaction [epigallocatechin gallate results in increased expression of MMP7 protein],,,PMID:17928719,https://www.ncbi.nlm.nih.gov/pubmed/17928719,17928719,,
257,36827,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606,Homo sapiens (human),Gallic acid results in decreased expression of MMP7 mRNA,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
258,36828,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55344,PLCXD1,https://ctdbase.org/detail.go?type=gene&acc=55344,,,55344.0,PLCXD1,9606,Homo sapiens (human),Gallic acid results in decreased expression of PLCXD1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
259,36829,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,25894,PLEKHG4,https://ctdbase.org/detail.go?type=gene&acc=25894,,,25894.0,PLEKHG4,9606,Homo sapiens (human),Gallic acid results in increased expression of PLEKHG4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
260,36830,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5358,PLS3,https://ctdbase.org/detail.go?type=gene&acc=5358,,,5358.0,PLS3,9606,Homo sapiens (human),Gallic acid results in decreased expression of PLS3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
261,36831,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mrna]|ep300 protein inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]|gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]|map2k1 inhibits the reaction [[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
262,36832,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased expression of and results in increased secretion of MMP9 protein],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
263,37031,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),Gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mrna],,,PMID:27087131|PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27087131|https://www.ncbi.nlm.nih.gov/pubmed/27634460,27087131|27634460,,
264,37032,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),Gallic acid results in decreased expression of MMP9 protein|gallic acid results in decreased activity of MMP9 protein|gallic acid results in decreased expression of MMP9 mRNA,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
265,37033,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090,Mus musculus (house mouse),Gallic acid results in decreased expression of MMP9 mRNA,,,PMID:16304905,https://www.ncbi.nlm.nih.gov/pubmed/16304905,16304905,,
266,37034,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP9 protein]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP9 mrna],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
267,37035,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,148932,MOB3C,https://ctdbase.org/detail.go?type=gene&acc=148932,,,148932.0,MOB3C,9606,Homo sapiens (human),Gallic acid results in increased expression of MOB3C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
268,37036,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23041,MON2,https://ctdbase.org/detail.go?type=gene&acc=23041,,,23041.0,MON2,9606,Homo sapiens (human),Gallic acid results in decreased expression of MON2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
269,37037,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Gallic acid results in decreased activity of MPO protein,,,PMID:24060682,https://www.ncbi.nlm.nih.gov/pubmed/24060682,24060682,,
270,37038,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased activity of MPO protein],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
271,37039,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in increased activity of MPO protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
272,37040,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9801,MRPL19,https://ctdbase.org/detail.go?type=gene&acc=9801,,,9801.0,MRPL19,9606,Homo sapiens (human),Gallic acid results in decreased expression of MRPL19 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
273,37231,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10943,MSL3,https://ctdbase.org/detail.go?type=gene&acc=10943,,,10943.0,MSL3,9606,Homo sapiens (human),Gallic acid results in decreased expression of MSL3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
274,37232,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,253827,MSRB3,https://ctdbase.org/detail.go?type=gene&acc=253827,,,253827.0,MSRB3,9606,Homo sapiens (human),Gallic acid results in decreased expression of MSRB3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
275,37233,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4524,MTHFR,https://ctdbase.org/detail.go?type=gene&acc=4524,,,4524.0,MTHFR,9606,Homo sapiens (human),Gallic acid results in decreased expression of MTHFR mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
276,37234,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,439921,MXRA7,https://ctdbase.org/detail.go?type=gene&acc=439921,,,439921.0,MXRA7,9606,Homo sapiens (human),Gallic acid results in decreased expression of MXRA7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
277,37235,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4430,MYO1B,https://ctdbase.org/detail.go?type=gene&acc=4430,,,4430.0,MYO1B,9606,Homo sapiens (human),Gallic acid results in increased expression of MYO1B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
278,37236,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7593,MZF1,https://ctdbase.org/detail.go?type=gene&acc=7593,,,7593.0,MZF1,9606,Homo sapiens (human),Gallic acid results in decreased expression of MZF1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
279,37237,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79903,NAA60,https://ctdbase.org/detail.go?type=gene&acc=79903,,,79903.0,NAA60,9606,Homo sapiens (human),Gallic acid results in decreased expression of NAA60 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
280,37238,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,24142,NAA80,https://ctdbase.org/detail.go?type=gene&acc=24142,,,24142.0,NAA80,9606,Homo sapiens (human),Gallic acid results in increased expression of NAA80 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
281,37239,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4676,NAP1L4,https://ctdbase.org/detail.go?type=gene&acc=4676,,,4676.0,NAP1L4,9606,Homo sapiens (human),Gallic acid results in decreased expression of NAP1L4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
282,37240,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26502,NARF,https://ctdbase.org/detail.go?type=gene&acc=26502,,,26502.0,NARF,9606,Homo sapiens (human),Gallic acid results in increased expression of NARF mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
283,37241,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,89795,NAV3,https://ctdbase.org/detail.go?type=gene&acc=89795,,,89795.0,NAV3,9606,Homo sapiens (human),Gallic acid results in increased expression of NAV3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
284,37448,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,101060684,NBPF26,https://ctdbase.org/detail.go?type=gene&acc=101060684,,,101060684.0,NBPF26,9606,Homo sapiens (human),Gallic acid results in increased expression of NBPF26 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
285,37449,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of NCF1 protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
286,37450,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4535,ND1,https://ctdbase.org/detail.go?type=gene&acc=4535,,,4535.0,ND1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
287,37451,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4696,NDUFA3,https://ctdbase.org/detail.go?type=gene&acc=4696,,,4696.0,NDUFA3,9606,Homo sapiens (human),Gallic acid results in increased expression of NDUFA3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
288,37452,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,137682,NDUFAF6,https://ctdbase.org/detail.go?type=gene&acc=137682,,,137682.0,NDUFAF6,9606,Homo sapiens (human),Gallic acid results in decreased expression of NDUFAF6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
289,37453,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4707,NDUFB1,https://ctdbase.org/detail.go?type=gene&acc=4707,,,4707.0,NDUFB1,9606,Homo sapiens (human),Gallic acid results in decreased expression of NDUFB1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
290,37454,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
291,37455,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79661,NEIL1,https://ctdbase.org/detail.go?type=gene&acc=79661,,,79661.0,NEIL1,9606,Homo sapiens (human),Gallic acid results in decreased expression of NEIL1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
292,37456,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,152110,NEK10,https://ctdbase.org/detail.go?type=gene&acc=152110,,,152110.0,NEK10,9606,Homo sapiens (human),Gallic acid results in decreased expression of NEK10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
293,37457,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,9606,Homo sapiens (human),Gallic acid results in decreased expression of NF1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
294,37656,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4776,NFATC4,https://ctdbase.org/detail.go?type=gene&acc=4776,,,4776.0,NFATC4,9606,Homo sapiens (human),Gallic acid results in decreased expression of NFATC4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
295,37657,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
296,37658,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5000,ORC4,https://ctdbase.org/detail.go?type=gene&acc=5000,,,5000.0,ORC4,9606,Homo sapiens (human),Gallic acid results in increased expression of ORC4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
297,37659,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,114880,OSBPL6,https://ctdbase.org/detail.go?type=gene&acc=114880,,,114880.0,OSBPL6,9606,Homo sapiens (human),Gallic acid results in increased expression of OSBPL6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
298,37660,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Gallic acid inhibits the reaction [ethanol results in decreased expression of NFE2L2 mrna]|nfe2l2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased secretion of HMGB1 protein]]|nfe2l2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased expression of RIPK3 mrna]]|gallic acid inhibits the reaction [ethanol results in decreased expression of NFE2L2 protein]|nfe2l2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased activity of GPT protein]],,,PMID:30853489,https://www.ncbi.nlm.nih.gov/pubmed/30853489,30853489,,
299,37661,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of NFE2L2 mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
300,37662,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),[gallic acid co-treated with dust] results in increased expression of NFE2L2 mRNA,,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
301,37663,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
302,37664,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,152518,NFXL1,https://ctdbase.org/detail.go?type=gene&acc=152518,,,152518.0,NFXL1,9606,Homo sapiens (human),Gallic acid results in decreased expression of NFXL1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
303,37665,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,60491,NIF3L1,https://ctdbase.org/detail.go?type=gene&acc=60491,,,60491.0,NIF3L1,9606,Homo sapiens (human),Gallic acid results in increased expression of NIF3L1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
304,37860,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55216,NKAPD1,https://ctdbase.org/detail.go?type=gene&acc=55216,,,55216.0,NKAPD1,9606,Homo sapiens (human),Gallic acid results in increased expression of NKAPD1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
305,37861,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22861,NLRP1,https://ctdbase.org/detail.go?type=gene&acc=22861,,,22861.0,NLRP1,9606,Homo sapiens (human),Gallic acid results in increased expression of NLRP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
306,37862,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [acrylamide results in increased secretion of NOS2 protein],,,PMID:37037409,https://www.ncbi.nlm.nih.gov/pubmed/37037409,37037409,,
307,37863,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of NOS2 protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
308,37864,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,115677,NOSTRIN,https://ctdbase.org/detail.go?type=gene&acc=115677,,,115677.0,NOSTRIN,9606,Homo sapiens (human),Gallic acid results in increased expression of NOSTRIN mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
309,37865,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,613037,NPIPB13,https://ctdbase.org/detail.go?type=gene&acc=613037,,,613037.0,NPIPB13,9606,Homo sapiens (human),Gallic acid results in increased expression of NPIPB13 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
310,37866,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
311,37867,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4898,NRDC,https://ctdbase.org/detail.go?type=gene&acc=4898,,,4898.0,NRDC,9606,Homo sapiens (human),Gallic acid results in decreased expression of NRDC mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
312,37868,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,123904,NRN1L,https://ctdbase.org/detail.go?type=gene&acc=123904,,,123904.0,NRN1L,9606,Homo sapiens (human),Gallic acid results in decreased expression of NRN1L mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
313,37869,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,80224,NUBPL,https://ctdbase.org/detail.go?type=gene&acc=80224,,,80224.0,NUBPL,9606,Homo sapiens (human),Gallic acid results in increased expression of NUBPL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
314,38065,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4931,NVL,https://ctdbase.org/detail.go?type=gene&acc=4931,,,4931.0,NVL,9606,Homo sapiens (human),Gallic acid results in increased expression of NVL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
315,38066,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [3-chloroperbenzoic acid results in increased activity of ODC1 protein],,,PMID:7653998,https://www.ncbi.nlm.nih.gov/pubmed/7653998,7653998,,
316,38067,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54953,ODR4,https://ctdbase.org/detail.go?type=gene&acc=54953,,,54953.0,ODR4,9606,Homo sapiens (human),Gallic acid results in decreased expression of ODR4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
317,38068,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,133015,PACRGL,https://ctdbase.org/detail.go?type=gene&acc=133015,,,133015.0,PACRGL,9606,Homo sapiens (human),Gallic acid results in decreased expression of PACRGL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
318,38069,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),"Gallic acid results in increased cleavage of PARP1 protein|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [gallic acid results in increased cleavage of PARP1 protein]",,,PMID:27060209,https://www.ncbi.nlm.nih.gov/pubmed/27060209,27060209,,
319,38070,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5095,PCCA,https://ctdbase.org/detail.go?type=gene&acc=5095,,,5095.0,PCCA,9606,Homo sapiens (human),Gallic acid results in decreased expression of PCCA mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
320,38071,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606,Homo sapiens (human),Gallic acid results in increased expression of PCK2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
321,38072,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PCNA protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
322,38073,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10611,PDLIM5,https://ctdbase.org/detail.go?type=gene&acc=10611,,,10611.0,PDLIM5,9606,Homo sapiens (human),Gallic acid results in decreased expression of PDLIM5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
323,38074,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3651,PDX1,https://ctdbase.org/detail.go?type=gene&acc=3651,,,3651.0,PDX1,10090,Mus musculus (house mouse),Gallic acid results in increased expression of PDX1 protein,,,PMID:24036142,https://www.ncbi.nlm.nih.gov/pubmed/24036142,24036142,,
324,38075,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5187,PER1,https://ctdbase.org/detail.go?type=gene&acc=5187,,,5187.0,PER1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of PER1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
325,38264,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8864,PER2,https://ctdbase.org/detail.go?type=gene&acc=8864,,,8864.0,PER2,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of PER2 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
326,38265,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5209,PFKFB3,https://ctdbase.org/detail.go?type=gene&acc=5209,,,5209.0,PFKFB3,9606,Homo sapiens (human),Gallic acid results in increased expression of PFKFB3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
327,38266,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,9606,Homo sapiens (human),Gallic acid results in increased expression of PFKM mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
328,38267,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9063,PIAS2,https://ctdbase.org/detail.go?type=gene&acc=9063,,,9063.0,PIAS2,9606,Homo sapiens (human),Gallic acid results in increased expression of PIAS2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
329,38268,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23760,PITPNB,https://ctdbase.org/detail.go?type=gene&acc=23760,,,23760.0,PITPNB,9606,Homo sapiens (human),Gallic acid results in decreased expression of PITPNB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
330,38269,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,50640,PNPLA8,https://ctdbase.org/detail.go?type=gene&acc=50640,,,50640.0,PNPLA8,9606,Homo sapiens (human),Gallic acid results in decreased expression of PNPLA8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
331,38270,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10940,POP1,https://ctdbase.org/detail.go?type=gene&acc=10940,,,10940.0,POP1,9606,Homo sapiens (human),Gallic acid results in increased expression of POP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
332,38271,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5451,POU2F1,https://ctdbase.org/detail.go?type=gene&acc=5451,,,5451.0,POU2F1,9606,Homo sapiens (human),Gallic acid results in decreased expression of POU2F1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
333,38272,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),Gallic acid results in increased expression of PPARG protein,,,PMID:24036142,https://www.ncbi.nlm.nih.gov/pubmed/24036142,24036142,,
334,38273,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116,Rattus norvegicus (Norway rat),Gallic acid results in increased activity of PPARG protein,,,PMID:24433871,https://www.ncbi.nlm.nih.gov/pubmed/24433871,24433871,,
335,38274,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,170954,PPP1R18,https://ctdbase.org/detail.go?type=gene&acc=170954,,,170954.0,PPP1R18,9606,Homo sapiens (human),Gallic acid results in increased expression of PPP1R18 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
336,38470,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55012,PPP2R3C,https://ctdbase.org/detail.go?type=gene&acc=55012,,,55012.0,PPP2R3C,9606,Homo sapiens (human),Gallic acid results in decreased expression of PPP2R3C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
337,38471,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5530,PPP3CA,https://ctdbase.org/detail.go?type=gene&acc=5530,,,5530.0,PPP3CA,9606,Homo sapiens (human),Gallic acid results in increased expression of PPP3CA mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
338,38472,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5538,PPT1,https://ctdbase.org/detail.go?type=gene&acc=5538,,,5538.0,PPT1,9606,Homo sapiens (human),Gallic acid results in decreased expression of PPT1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
339,38473,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,56980,PRDM10,https://ctdbase.org/detail.go?type=gene&acc=56980,,,56980.0,PRDM10,9606,Homo sapiens (human),Gallic acid results in increased expression of PRDM10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
340,38474,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,63977,PRDM15,https://ctdbase.org/detail.go?type=gene&acc=63977,,,63977.0,PRDM15,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRDM15 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
341,38475,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11107,PRDM5,https://ctdbase.org/detail.go?type=gene&acc=11107,,,11107.0,PRDM5,9606,Homo sapiens (human),Gallic acid results in increased expression of PRDM5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
342,38476,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5567,PRKACB,https://ctdbase.org/detail.go?type=gene&acc=5567,,,5567.0,PRKACB,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRKACB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
343,38477,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606,Homo sapiens (human),Gallic acid results in decreased activity of PRKCA protein,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
344,38478,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5583,PRKCH,https://ctdbase.org/detail.go?type=gene&acc=5583,,,5583.0,PRKCH,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRKCH mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
345,38479,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRKDC mRNA,,,PMID:21887735,https://www.ncbi.nlm.nih.gov/pubmed/21887735,21887735,,
346,38480,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,3276,PRMT1,https://ctdbase.org/detail.go?type=gene&acc=3276,,,3276.0,PRMT1,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRMT1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
347,38677,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5635,PRPSAP1,https://ctdbase.org/detail.go?type=gene&acc=5635,,,5635.0,PRPSAP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of PRPSAP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
348,38678,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54458,PRR13,https://ctdbase.org/detail.go?type=gene&acc=54458,,,54458.0,PRR13,9606,Homo sapiens (human),Gallic acid results in increased expression of PRR13 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
349,38679,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,158471,PRUNE2,https://ctdbase.org/detail.go?type=gene&acc=158471,,,158471.0,PRUNE2,9606,Homo sapiens (human),Gallic acid results in increased expression of PRUNE2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
350,38680,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606,Homo sapiens (human),Gallic acid results in increased secretion of PTEN protein,,,PMID:26530725,https://www.ncbi.nlm.nih.gov/pubmed/26530725,26530725,,
351,38681,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9317,PTER,https://ctdbase.org/detail.go?type=gene&acc=9317,,,9317.0,PTER,9606,Homo sapiens (human),Gallic acid results in decreased expression of PTER mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
352,38682,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Gallic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of PTGS2 mrna],,,PMID:24836925,https://www.ncbi.nlm.nih.gov/pubmed/24836925,24836925,,
353,38683,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of PTGS2 mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
354,38684,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Gallic acid promotes the reaction [imatinib mesylate results in decreased expression of PTGS2 protein]|gallic acid results in decreased expression of PTGS2 protein|imatinib mesylate promotes the reaction [gallic acid results in decreased expression of PTGS2 protein]|gallic acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein],,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
355,38685,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PTGS2 protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
356,38686,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,9606,Homo sapiens (human),Gallic acid results in decreased expression of PTPRF mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
357,38883,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5795,PTPRJ,https://ctdbase.org/detail.go?type=gene&acc=5795,,,5795.0,PTPRJ,9606,Homo sapiens (human),Gallic acid results in decreased expression of PTPRJ mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
358,38884,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5796,PTPRK,https://ctdbase.org/detail.go?type=gene&acc=5796,,,5796.0,PTPRK,9606,Homo sapiens (human),Gallic acid results in increased expression of PTPRK mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
359,38885,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,138428,PTRH1,https://ctdbase.org/detail.go?type=gene&acc=138428,,,138428.0,PTRH1,9606,Homo sapiens (human),Gallic acid results in increased expression of PTRH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
360,38886,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83480,PUS3,https://ctdbase.org/detail.go?type=gene&acc=83480,,,83480.0,PUS3,9606,Homo sapiens (human),Gallic acid results in decreased expression of PUS3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
361,38887,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,9606,Homo sapiens (human),Gallic acid results in decreased expression of PYCARD mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
362,38888,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,27314,RAB30,https://ctdbase.org/detail.go?type=gene&acc=27314,,,27314.0,RAB30,9606,Homo sapiens (human),Gallic acid results in decreased expression of RAB30 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
363,38889,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11158,RABL2B,https://ctdbase.org/detail.go?type=gene&acc=11158,,,11158.0,RABL2B,9606,Homo sapiens (human),Gallic acid results in increased expression of RABL2B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
364,38890,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606,Homo sapiens (human),Gallic acid results in decreased expression of RAC1 protein,,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
365,38891,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29127,RACGAP1,https://ctdbase.org/detail.go?type=gene&acc=29127,,,29127.0,RACGAP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of RACGAP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
366,38892,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606,Homo sapiens (human),Gallic acid results in increased expression of RAD51 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
367,38893,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5908,RAP1B,https://ctdbase.org/detail.go?type=gene&acc=5908,,,5908.0,RAP1B,9606,Homo sapiens (human),Gallic acid results in decreased expression of RAP1B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
368,39089,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55225,RAVER2,https://ctdbase.org/detail.go?type=gene&acc=55225,,,55225.0,RAVER2,9606,Homo sapiens (human),Gallic acid results in decreased expression of RAVER2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
369,39090,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23543,RBFOX2,https://ctdbase.org/detail.go?type=gene&acc=23543,,,23543.0,RBFOX2,9606,Homo sapiens (human),Gallic acid results in increased expression of RBFOX2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
370,39091,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[gallic acid binds to gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein],,,PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27634460,27634460,,
371,39092,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein],,,PMID:27087131|PMID:27634460,https://www.ncbi.nlm.nih.gov/pubmed/27087131|https://www.ncbi.nlm.nih.gov/pubmed/27634460,27087131|27634460,,
372,39093,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein affects the localization of and affects the activity of RELA protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
373,39094,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Gallic acid results in decreased expression of RELA protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
374,39095,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
375,39096,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),Gallic acid analog results in increased activity of RELA protein,,,PMID:19577552,https://www.ncbi.nlm.nih.gov/pubmed/19577552,19577552,,
376,39097,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of RELA protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
377,39098,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [glucose results in increased expression of RELA protein]|gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of RELA protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
378,39292,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,57614,RELCH,https://ctdbase.org/detail.go?type=gene&acc=57614,,,57614.0,RELCH,9606,Homo sapiens (human),Gallic acid results in decreased expression of RELCH mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
379,39293,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,117584,RFFL,https://ctdbase.org/detail.go?type=gene&acc=117584,,,117584.0,RFFL,9606,Homo sapiens (human),Gallic acid results in increased expression of RFFL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
380,39294,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8601,RGS20,https://ctdbase.org/detail.go?type=gene&acc=8601,,,8601.0,RGS20,9606,Homo sapiens (human),Gallic acid results in increased expression of RGS20 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
381,39295,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606,Homo sapiens (human),Gallic acid results in decreased expression of RHOA protein,,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
382,39296,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,9606,Homo sapiens (human),Gallic acid results in increased expression of RHOB mrna|rhob mutant form inhibits the reaction [gallic acid results in decreased expression of MMP2 protein]|gallic acid results in increased expression of RHOB protein|rhob protein results in increased susceptibility to gallic acid|rhob mutant form inhibits the reaction [gallic acid results in decreased phosphorylation of AKT1 protein],,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
383,39297,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8737,RIPK1,https://ctdbase.org/detail.go?type=gene&acc=8737,,,8737.0,RIPK1,9606,Homo sapiens (human),Gallic acid inhibits the reaction [ethanol results in increased expression of RIPK1 protein],,,PMID:30853489,https://www.ncbi.nlm.nih.gov/pubmed/30853489,30853489,,
384,39298,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11035,RIPK3,https://ctdbase.org/detail.go?type=gene&acc=11035,,,11035.0,RIPK3,9606,Homo sapiens (human),NFE2L2 protein affects the reaction [gallic acid inhibits the reaction [ethanol results in increased expression of RIPK3 mrna]]|gallic acid inhibits the reaction [ethanol results in increased expression of RIPK3 protein]|gallic acid inhibits the reaction [ethanol results in increased expression of RIPK3 mrna],,,PMID:30853489,https://www.ncbi.nlm.nih.gov/pubmed/30853489,30853489,,
385,39299,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79621,RNASEH2B,https://ctdbase.org/detail.go?type=gene&acc=79621,,,79621.0,RNASEH2B,9606,Homo sapiens (human),Gallic acid results in decreased expression of RNASEH2B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
386,39300,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10921,RNPS1,https://ctdbase.org/detail.go?type=gene&acc=10921,,,10921.0,RNPS1,9606,Homo sapiens (human),Gallic acid results in decreased expression of RNPS1 mrna|gallic acid results in increased expression of RNPS1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
387,39301,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6161,RPL32,https://ctdbase.org/detail.go?type=gene&acc=6161,,,6161.0,RPL32,9606,Homo sapiens (human),Gallic acid results in decreased expression of RPL32 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
388,39487,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6125,RPL5,https://ctdbase.org/detail.go?type=gene&acc=6125,,,6125.0,RPL5,9606,Homo sapiens (human),Gallic acid results in increased expression of RPL5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
389,39488,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA1 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
390,39489,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9252,RPS6KA5,https://ctdbase.org/detail.go?type=gene&acc=9252,,,9252.0,RPS6KA5,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
391,39490,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26750,RPS6KC1,https://ctdbase.org/detail.go?type=gene&acc=26750,,,26750.0,RPS6KC1,9606,Homo sapiens (human),Gallic acid results in increased expression of RPS6KC1 mrna|gallic acid results in decreased expression of RPS6KC1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
392,39491,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6253,RTN2,https://ctdbase.org/detail.go?type=gene&acc=6253,,,6253.0,RTN2,9606,Homo sapiens (human),Gallic acid results in decreased expression of RTN2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
393,39492,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,64755,RUSF1,https://ctdbase.org/detail.go?type=gene&acc=64755,,,64755.0,RUSF1,9606,Homo sapiens (human),Gallic acid results in increased expression of RUSF1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
394,39493,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79634,SCRN3,https://ctdbase.org/detail.go?type=gene&acc=79634,,,79634.0,SCRN3,9606,Homo sapiens (human),Gallic acid results in decreased expression of SCRN3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
395,39494,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,113675,SDSL,https://ctdbase.org/detail.go?type=gene&acc=113675,,,113675.0,SDSL,9606,Homo sapiens (human),Gallic acid results in decreased expression of SDSL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
396,39495,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26984,SEC22A,https://ctdbase.org/detail.go?type=gene&acc=26984,,,26984.0,SEC22A,9606,Homo sapiens (human),Gallic acid results in increased expression of SEC22A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
397,39496,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10483,SEC23B,https://ctdbase.org/detail.go?type=gene&acc=10483,,,10483.0,SEC23B,9606,Homo sapiens (human),Gallic acid results in decreased expression of SEC23B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
398,39497,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of SELE protein],,,PMID:30611791,https://www.ncbi.nlm.nih.gov/pubmed/30611791,30611791,,
399,39692,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9403,SELENOF,https://ctdbase.org/detail.go?type=gene&acc=9403,,,9403.0,SELENOF,9606,Homo sapiens (human),Gallic acid results in increased expression of SELENOF mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
400,39693,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9869,SETDB1,https://ctdbase.org/detail.go?type=gene&acc=9869,,,9869.0,SETDB1,9606,Homo sapiens (human),Gallic acid results in decreased expression of SETDB1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
401,39694,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8910,SGCE,https://ctdbase.org/detail.go?type=gene&acc=8910,,,8910.0,SGCE,9606,Homo sapiens (human),Gallic acid results in increased expression of SGCE mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
402,39695,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of SIRT1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
403,39696,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,122060,SLAIN1,https://ctdbase.org/detail.go?type=gene&acc=122060,,,122060.0,SLAIN1,9606,Homo sapiens (human),Gallic acid results in increased expression of SLAIN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
404,39697,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6558,SLC12A2,https://ctdbase.org/detail.go?type=gene&acc=6558,,,6558.0,SLC12A2,9606,Homo sapiens (human),Gallic acid results in increased expression of SLC12A2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
405,39698,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84561,SLC12A8,https://ctdbase.org/detail.go?type=gene&acc=84561,,,84561.0,SLC12A8,9606,Homo sapiens (human),Gallic acid results in decreased expression of SLC12A8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
406,39699,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79085,SLC25A23,https://ctdbase.org/detail.go?type=gene&acc=79085,,,79085.0,SLC25A23,9606,Homo sapiens (human),Gallic acid results in decreased expression of SLC25A23 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
407,39700,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29988,SLC2A8,https://ctdbase.org/detail.go?type=gene&acc=29988,,,29988.0,SLC2A8,9606,Homo sapiens (human),Gallic acid results in decreased expression of SLC2A8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
408,39701,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23443,SLC35A3,https://ctdbase.org/detail.go?type=gene&acc=23443,,,23443.0,SLC35A3,9606,Homo sapiens (human),Gallic acid results in increased expression of SLC35A3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
409,39702,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,728661,SLC35E2B,https://ctdbase.org/detail.go?type=gene&acc=728661,,,728661.0,SLC35E2B,9606,Homo sapiens (human),Gallic acid results in decreased expression of SLC35E2B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
410,39900,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22950,SLC4A1AP,https://ctdbase.org/detail.go?type=gene&acc=22950,,,22950.0,SLC4A1AP,9606,Homo sapiens (human),Gallic acid results in increased expression of SLC4A1AP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
411,39901,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,133308,SLC9B2,https://ctdbase.org/detail.go?type=gene&acc=133308,,,133308.0,SLC9B2,9606,Homo sapiens (human),Gallic acid results in decreased expression of SLC9B2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
412,39902,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in increased phosphorylation of SMAD3 protein],,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
413,39903,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4089,SMAD4,https://ctdbase.org/detail.go?type=gene&acc=4089,,,4089.0,SMAD4,9606,Homo sapiens (human),Gallic acid results in increased expression of SMAD4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
414,39904,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6597,SMARCA4,https://ctdbase.org/detail.go?type=gene&acc=6597,,,6597.0,SMARCA4,9606,Homo sapiens (human),Gallic acid results in decreased expression of SMARCA4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
415,39905,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6605,SMARCE1,https://ctdbase.org/detail.go?type=gene&acc=6605,,,6605.0,SMARCE1,9606,Homo sapiens (human),Gallic acid results in decreased expression of SMARCE1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
416,39906,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,9606,Homo sapiens (human),Gallic acid inhibits the reaction [SNCA protein binds to SNCA protein],,,PMID:20150427,https://www.ncbi.nlm.nih.gov/pubmed/20150427,20150427,,
417,39907,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29934,SNX12,https://ctdbase.org/detail.go?type=gene&acc=29934,,,29934.0,SNX12,9606,Homo sapiens (human),Gallic acid results in increased expression of SNX12 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
418,39908,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9986,Oryctolagus cuniculus (rabbit),Gallic acid results in decreased expression of SOX9 mRNA,,,PMID:25130855,https://www.ncbi.nlm.nih.gov/pubmed/25130855,25130855,,
419,39909,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,10116,Rattus norvegicus (Norway rat),Gallic acid results in decreased expression of SOX9 mRNA,,,PMID:26107568,https://www.ncbi.nlm.nih.gov/pubmed/26107568,26107568,,
420,39910,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26010,SPATS2L,https://ctdbase.org/detail.go?type=gene&acc=26010,,,26010.0,SPATS2L,9606,Homo sapiens (human),Gallic acid results in decreased expression of SPATS2L mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
421,40104,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,56848,SPHK2,https://ctdbase.org/detail.go?type=gene&acc=56848,,,56848.0,SPHK2,9606,Homo sapiens (human),Gallic acid results in increased expression of SPHK2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
422,40105,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6709,SPTAN1,https://ctdbase.org/detail.go?type=gene&acc=6709,,,6709.0,SPTAN1,9606,Homo sapiens (human),Gallic acid results in decreased expression of SPTAN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
423,40106,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606,Homo sapiens (human),SRC protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]]|gallic acid inhibits the reaction [EGF protein results in increased activity of SRC protein]|src protein modified form affects the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
424,40107,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,30815,ST6GALNAC6,https://ctdbase.org/detail.go?type=gene&acc=30815,,,30815.0,ST6GALNAC6,9606,Homo sapiens (human),Gallic acid results in increased expression of ST6GALNAC6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
425,40108,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10274,STAG1,https://ctdbase.org/detail.go?type=gene&acc=10274,,,10274.0,STAG1,9606,Homo sapiens (human),Gallic acid results in decreased expression of STAG1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
426,40109,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10809,STARD10,https://ctdbase.org/detail.go?type=gene&acc=10809,,,10809.0,STARD10,9606,Homo sapiens (human),Gallic acid results in increased expression of STARD10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
427,40110,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,27067,STAU2,https://ctdbase.org/detail.go?type=gene&acc=27067,,,27067.0,STAU2,9606,Homo sapiens (human),Gallic acid results in increased expression of STAU2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
428,40111,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,63932,STEEP1,https://ctdbase.org/detail.go?type=gene&acc=63932,,,63932.0,STEEP1,9606,Homo sapiens (human),Gallic acid results in increased expression of STEEP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
429,40112,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),Dactinomycin inhibits the reaction [gallic acid results in increased expression of SULT1A1 mrna]|sb 203580 inhibits the reaction [gallic acid results in increased expression of SULT1A1 protein]|cycloheximide inhibits the reaction [gallic acid results in increased expression of SULT1A1 mrna]|gallic acid results in increased expression of SULT1A1 protein|gallic acid results in increased activity of SULT1A1 protein|pyrazolanthrone inhibits the reaction [gallic acid results in increased expression of SULT1A1 protein],,,PMID:16308312,https://www.ncbi.nlm.nih.gov/pubmed/16308312,16308312,,
430,40313,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10116,Rattus norvegicus (Norway rat),Gallic acid results in increased expression of SULT1A1 mrna|gallic acid results in increased activity of SULT1A1 protein,,,PMID:16443358,https://www.ncbi.nlm.nih.gov/pubmed/16443358,16443358,,
431,40314,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,10116,Rattus norvegicus (Norway rat),Gallic acid results in increased expression of SULT2A1 mrna|gallic acid results in increased activity of SULT2A1 protein,,,PMID:16443358,https://www.ncbi.nlm.nih.gov/pubmed/16443358,16443358,,
432,40315,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,9606,Homo sapiens (human),Gallic acid results in decreased expression of SUMF2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
433,40316,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6829,SUPT5H,https://ctdbase.org/detail.go?type=gene&acc=6829,,,6829.0,SUPT5H,9606,Homo sapiens (human),Gallic acid results in increased expression of SUPT5H mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
434,40317,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55638,SYBU,https://ctdbase.org/detail.go?type=gene&acc=55638,,,55638.0,SYBU,9606,Homo sapiens (human),Gallic acid results in decreased expression of SYBU mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
435,40318,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9606,Homo sapiens (human),Gallic acid results in decreased expression of SYNJ2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
436,40319,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6856,SYPL1,https://ctdbase.org/detail.go?type=gene&acc=6856,,,6856.0,SYPL1,9606,Homo sapiens (human),Gallic acid results in decreased expression of SYPL1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
437,40320,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10460,TACC3,https://ctdbase.org/detail.go?type=gene&acc=10460,,,10460.0,TACC3,9606,Homo sapiens (human),Gallic acid results in decreased expression of TACC3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
438,40321,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,391746,TAF11L4,https://ctdbase.org/detail.go?type=gene&acc=391746,,,391746.0,TAF11L4,9606,Homo sapiens (human),Gallic acid results in decreased expression of TAF11L4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
439,40322,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6878,TAF6,https://ctdbase.org/detail.go?type=gene&acc=6878,,,6878.0,TAF6,9606,Homo sapiens (human),Gallic acid results in increased expression of TAF6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
440,40323,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8887,TAX1BP1,https://ctdbase.org/detail.go?type=gene&acc=8887,,,8887.0,TAX1BP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of TAX1BP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
441,40535,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,64786,TBC1D15,https://ctdbase.org/detail.go?type=gene&acc=64786,,,64786.0,TBC1D15,9606,Homo sapiens (human),Gallic acid results in increased expression of TBC1D15 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
442,40536,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23102,TBC1D2B,https://ctdbase.org/detail.go?type=gene&acc=23102,,,23102.0,TBC1D2B,9606,Homo sapiens (human),Gallic acid results in decreased expression of TBC1D2B mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
443,40537,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1155,TBCB,https://ctdbase.org/detail.go?type=gene&acc=1155,,,1155.0,TBCB,9606,Homo sapiens (human),Gallic acid results in decreased expression of TBCB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
444,40538,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6913,TBX15,https://ctdbase.org/detail.go?type=gene&acc=6913,,,6913.0,TBX15,9606,Homo sapiens (human),Gallic acid results in decreased expression of TBX15 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
445,40539,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,9606,Homo sapiens (human),Gallic acid results in decreased expression of TCF7L2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
446,40540,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8463,TEAD2,https://ctdbase.org/detail.go?type=gene&acc=8463,,,8463.0,TEAD2,9606,Homo sapiens (human),Gallic acid results in decreased expression of TEAD2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
447,40541,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51368,TEX264,https://ctdbase.org/detail.go?type=gene&acc=51368,,,51368.0,TEX264,9606,Homo sapiens (human),Gallic acid results in decreased expression of TEX264 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
448,40542,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of TGFB1 protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
449,40543,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [streptozocin results in increased expression of TGFB1 protein],,,PMID:29331653,https://www.ncbi.nlm.nih.gov/pubmed/29331653,29331653,,
450,40544,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in increased expression of TGFB1 protein],,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
451,40545,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,92609,TIMM50,https://ctdbase.org/detail.go?type=gene&acc=92609,,,92609.0,TIMM50,9606,Homo sapiens (human),Gallic acid results in increased expression of TIMM50 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
452,40703,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of TIMP1 mrna],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
453,40704,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of TIMP2 mrna],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
454,40705,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in decreased expression of TIMP3 mrna],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
455,40706,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26277,TINF2,https://ctdbase.org/detail.go?type=gene&acc=26277,,,26277.0,TINF2,9606,Homo sapiens (human),Gallic acid results in increased expression of TINF2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
456,40707,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7084,TK2,https://ctdbase.org/detail.go?type=gene&acc=7084,,,7084.0,TK2,9606,Homo sapiens (human),Gallic acid results in decreased expression of TK2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
457,40708,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51768,TM7SF3,https://ctdbase.org/detail.go?type=gene&acc=51768,,,51768.0,TM7SF3,9606,Homo sapiens (human),Gallic acid results in decreased expression of TM7SF3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
458,40709,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7009,TMBIM6,https://ctdbase.org/detail.go?type=gene&acc=7009,,,7009.0,TMBIM6,9606,Homo sapiens (human),Gallic acid results in increased expression of TMBIM6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
459,40710,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79022,TMEM106C,https://ctdbase.org/detail.go?type=gene&acc=79022,,,79022.0,TMEM106C,9606,Homo sapiens (human),Gallic acid results in decreased expression of TMEM106C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
460,40711,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,92305,TMEM129,https://ctdbase.org/detail.go?type=gene&acc=92305,,,92305.0,TMEM129,9606,Homo sapiens (human),Gallic acid results in increased expression of TMEM129 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
461,40712,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,124491,TMEM170A,https://ctdbase.org/detail.go?type=gene&acc=124491,,,124491.0,TMEM170A,9606,Homo sapiens (human),Gallic acid results in increased expression of TMEM170A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
462,40713,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,374882,TMEM205,https://ctdbase.org/detail.go?type=gene&acc=374882,,,374882.0,TMEM205,9606,Homo sapiens (human),Gallic acid results in increased expression of TMEM205 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
463,40913,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,219854,TMEM218,https://ctdbase.org/detail.go?type=gene&acc=219854,,,219854.0,TMEM218,9606,Homo sapiens (human),Gallic acid results in decreased expression of TMEM218 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
464,40914,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,90120,TMEM250,https://ctdbase.org/detail.go?type=gene&acc=90120,,,90120.0,TMEM250,9606,Homo sapiens (human),Gallic acid results in decreased expression of TMEM250 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
465,40915,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83590,TMUB1,https://ctdbase.org/detail.go?type=gene&acc=83590,,,83590.0,TMUB1,9606,Homo sapiens (human),Gallic acid results in increased expression of TMUB1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
466,40916,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9031,Gallus gallus (chicken),Gallic acid results in increased expression of TNF protein,,,PMID:23406025,https://www.ncbi.nlm.nih.gov/pubmed/23406025,23406025,,
467,40917,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of IL6 mrna]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K1 protein]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK8 protein]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein]|gallic acid inhibits the reaction [TNF protein results in increased secretion of IL6 protein]|gallic acid inhibits the reaction [TNF protein results in increased expression of BCL2 mrna]|gallic acid inhibits the reaction [TNF protein results in increased expression of CXCR4 mrna]|gallic acid inhibits the reaction [TNF protein affects the localization of and affects the activity of RELA protein]|gallic acid inhibits the reaction [TNF protein results in increased expression of PTGS2 mrna]|gallic acid inhibits the reaction [TNF protein results in increased expression of VEGFA mrna]|gallic acid inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein]|gallic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein]|gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA1 protein]|gallic acid inhibits the reaction [TNF protein results in increased expression of XIAP mrna]|gallic acid inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
468,40918,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of SELE protein],,,PMID:30611791,https://www.ncbi.nlm.nih.gov/pubmed/30611791,30611791,,
469,40919,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [diethylhexyl phthalate results in increased expression of TNF protein],,,PMID:35196152,https://www.ncbi.nlm.nih.gov/pubmed/35196152,35196152,,
470,40920,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:31306686,https://www.ncbi.nlm.nih.gov/pubmed/31306686,31306686,,
471,41116,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid affects the reaction [[dietary fats co-treated with dust] affects the expression of TNF mrna],,,PMID:34745924,https://www.ncbi.nlm.nih.gov/pubmed/34745924,34745924,,
472,41117,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of TNF protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
473,41118,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [cobaltous chloride results in increased expression of TNF protein],,,PMID:31362009,https://www.ncbi.nlm.nih.gov/pubmed/31362009,31362009,,
474,41119,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [dust results in increased expression of TNF mrna],,,PMID:33953864,https://www.ncbi.nlm.nih.gov/pubmed/33953864,33953864,,
475,41120,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of TNF protein]|gallic acid inhibits the reaction [glucose results in increased secretion of TNF protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
476,41121,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in increased expression of TNF protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
477,41122,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7128,TNFAIP3,https://ctdbase.org/detail.go?type=gene&acc=7128,,,7128.0,TNFAIP3,9606,Homo sapiens (human),Gallic acid results in increased expression of TNFAIP3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
478,41123,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,126282,TNFAIP8L1,https://ctdbase.org/detail.go?type=gene&acc=126282,,,126282.0,TNFAIP8L1,9606,Homo sapiens (human),Gallic acid results in decreased expression of TNFAIP8L1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
479,41124,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7139,TNNT2,https://ctdbase.org/detail.go?type=gene&acc=7139,,,7139.0,TNNT2,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in increased secretion of TNNT2 protein],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
480,41125,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of TP53 protein|[paclitaxel co-treated with gallic acid] results in increased expression of TP53 protein|[paclitaxel co-treated with gallic acid] results in increased expression of TP53 mrna|[gallic acid co-treated with carboplatin] results in increased expression of TP53 mrna|[carboplatin co-treated with gallic acid] results in increased expression of TP53 protein|[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of TP53 mrna|gallic acid results in increased expression of TP53 mrna|gallic acid results in increased expression of TP53 protein,,,PMID:33002289,https://www.ncbi.nlm.nih.gov/pubmed/33002289,33002289,,
481,41295,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Gallic acid results in decreased expression of TP53 mRNA,,,PMID:21887735,https://www.ncbi.nlm.nih.gov/pubmed/21887735,21887735,,
482,41296,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7170,TPM3,https://ctdbase.org/detail.go?type=gene&acc=7170,,,7170.0,TPM3,9606,Homo sapiens (human),Gallic acid results in decreased expression of TPM3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
483,41297,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7188,TRAF5,https://ctdbase.org/detail.go?type=gene&acc=7188,,,7188.0,TRAF5,9606,Homo sapiens (human),Gallic acid results in decreased expression of TRAF5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
484,41298,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10293,TRAIP,https://ctdbase.org/detail.go?type=gene&acc=10293,,,10293.0,TRAIP,9606,Homo sapiens (human),Gallic acid results in decreased expression of TRAIP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
485,41299,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83696,TRAPPC9,https://ctdbase.org/detail.go?type=gene&acc=83696,,,83696.0,TRAPPC9,9606,Homo sapiens (human),Gallic acid results in increased expression of TRAPPC9 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
486,41300,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55521,TRIM36,https://ctdbase.org/detail.go?type=gene&acc=55521,,,55521.0,TRIM36,9606,Homo sapiens (human),Gallic acid results in increased expression of TRIM36 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
487,41301,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,80263,TRIM45,https://ctdbase.org/detail.go?type=gene&acc=80263,,,80263.0,TRIM45,9606,Homo sapiens (human),Gallic acid results in decreased expression of TRIM45 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
488,41302,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,286144,TRIQK,https://ctdbase.org/detail.go?type=gene&acc=286144,,,286144.0,TRIQK,9606,Homo sapiens (human),Gallic acid results in decreased expression of TRIQK mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
489,41303,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,93587,TRMT10A,https://ctdbase.org/detail.go?type=gene&acc=93587,,,93587.0,TRMT10A,9606,Homo sapiens (human),Gallic acid results in decreased expression of TRMT10A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
490,41304,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7224,TRPC5,https://ctdbase.org/detail.go?type=gene&acc=7224,,,7224.0,TRPC5,9606,Homo sapiens (human),Gallic acid inhibits the reaction [hydrogen peroxide promotes the reaction [TRPC5 protein results in increased transport of calcium]]|gallic acid inhibits the reaction [gadolinium promotes the reaction [TRPC5 protein results in increased transport of calcium]],,,PMID:21127073,https://www.ncbi.nlm.nih.gov/pubmed/21127073,21127073,,
491,41305,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1831,TSC22D3,https://ctdbase.org/detail.go?type=gene&acc=1831,,,1831.0,TSC22D3,9606,Homo sapiens (human),Gallic acid results in increased expression of TSC22D3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
492,41485,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7252,TSHB,https://ctdbase.org/detail.go?type=gene&acc=7252,,,7252.0,TSHB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in decreased expression of TSHB protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
493,41486,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10867,TSPAN9,https://ctdbase.org/detail.go?type=gene&acc=10867,,,10867.0,TSPAN9,9606,Homo sapiens (human),Gallic acid results in decreased expression of TSPAN9 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
494,41487,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79183,TTPAL,https://ctdbase.org/detail.go?type=gene&acc=79183,,,79183.0,TTPAL,9606,Homo sapiens (human),Gallic acid results in decreased expression of TTPAL mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
495,41488,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7311,UBA52,https://ctdbase.org/detail.go?type=gene&acc=7311,,,7311.0,UBA52,9606,Homo sapiens (human),Gallic acid results in decreased expression of UBA52 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
496,41489,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7314,UBB,https://ctdbase.org/detail.go?type=gene&acc=7314,,,7314.0,UBB,9606,Homo sapiens (human),Gallic acid results in decreased expression of UBB mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
497,41490,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,118424,UBE2J2,https://ctdbase.org/detail.go?type=gene&acc=118424,,,118424.0,UBE2J2,9606,Homo sapiens (human),Gallic acid results in decreased expression of UBE2J2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
498,41491,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,80700,UBXN6,https://ctdbase.org/detail.go?type=gene&acc=80700,,,80700.0,UBXN6,9606,Homo sapiens (human),Gallic acid results in increased expression of UBXN6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
499,41492,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55245,UQCC1,https://ctdbase.org/detail.go?type=gene&acc=55245,,,55245.0,UQCC1,9606,Homo sapiens (human),Gallic acid results in increased expression of UQCC1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
500,41493,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7385,UQCRC2,https://ctdbase.org/detail.go?type=gene&acc=7385,,,7385.0,UQCRC2,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
501,41494,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,100534592,URGCP-MRPS24,https://ctdbase.org/detail.go?type=gene&acc=100534592,,,100534592.0,URGCP-MRPS24,9606,Homo sapiens (human),Gallic acid results in decreased expression of URGCP-MRPS24 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
502,41686,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10869,USP19,https://ctdbase.org/detail.go?type=gene&acc=10869,,,10869.0,USP19,9606,Homo sapiens (human),Gallic acid results in increased expression of USP19 mrna|gallic acid results in decreased expression of USP19 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
503,41687,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9099,USP2,https://ctdbase.org/detail.go?type=gene&acc=9099,,,9099.0,USP2,9606,Homo sapiens (human),Gallic acid results in decreased expression of USP2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
504,41688,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,27005,USP21,https://ctdbase.org/detail.go?type=gene&acc=27005,,,27005.0,USP21,9606,Homo sapiens (human),Gallic acid results in decreased expression of USP21 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
505,41689,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9960,USP3,https://ctdbase.org/detail.go?type=gene&acc=9960,,,9960.0,USP3,9606,Homo sapiens (human),Gallic acid results in increased expression of USP3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
506,41690,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84669,USP32,https://ctdbase.org/detail.go?type=gene&acc=84669,,,84669.0,USP32,9606,Homo sapiens (human),Gallic acid results in decreased expression of USP32 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
507,41691,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,85015,USP45,https://ctdbase.org/detail.go?type=gene&acc=85015,,,85015.0,USP45,9606,Homo sapiens (human),Gallic acid results in decreased expression of USP45 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
508,41692,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7402,UTRN,https://ctdbase.org/detail.go?type=gene&acc=7402,,,7402.0,UTRN,9606,Homo sapiens (human),Gallic acid results in increased expression of UTRN mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
509,41693,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased expression of VCAM1 mrna],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
510,41694,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9031,Gallus gallus (chicken),Gallic acid results in decreased expression of VEGFA protein,,,PMID:23406025,https://www.ncbi.nlm.nih.gov/pubmed/23406025,23406025,,
511,41695,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),HIF1A protein inhibits the reaction [gallic acid results in decreased expression of VEGFA mrna]|akt1 protein inhibits the reaction [gallic acid results in decreased expression of VEGFA mrna]|gallic acid results in decreased secretion of VEGFA protein|gallic acid results in decreased expression of VEGFA mRNA,,,PMID:26530725,https://www.ncbi.nlm.nih.gov/pubmed/26530725,26530725,,
512,41904,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of VEGFA mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
513,41905,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7433,VIPR1,https://ctdbase.org/detail.go?type=gene&acc=7433,,,7433.0,VIPR1,9606,Homo sapiens (human),Gallic acid results in increased expression of VIPR1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
514,41906,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,4013,VWA5A,https://ctdbase.org/detail.go?type=gene&acc=4013,,,4013.0,VWA5A,9606,Homo sapiens (human),Gallic acid results in decreased expression of VWA5A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
515,41907,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7453,WARS1,https://ctdbase.org/detail.go?type=gene&acc=7453,,,7453.0,WARS1,9606,Homo sapiens (human),Gallic acid results in increased expression of WARS1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
516,41908,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8936,WASF1,https://ctdbase.org/detail.go?type=gene&acc=8936,,,8936.0,WASF1,9606,Homo sapiens (human),Gallic acid results in increased expression of WASF1 mrna|gallic acid results in decreased expression of WASF1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
517,41909,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,253725,WASHC2C,https://ctdbase.org/detail.go?type=gene&acc=253725,,,253725.0,WASHC2C,9606,Homo sapiens (human),Gallic acid results in decreased expression of WASHC2C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
518,41910,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79446,WDR25,https://ctdbase.org/detail.go?type=gene&acc=79446,,,79446.0,WDR25,9606,Homo sapiens (human),Gallic acid results in decreased expression of WDR25 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
519,41911,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,124997,WDR81,https://ctdbase.org/detail.go?type=gene&acc=124997,,,124997.0,WDR81,9606,Homo sapiens (human),Gallic acid results in increased expression of WDR81 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
520,41912,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,65268,WNK2,https://ctdbase.org/detail.go?type=gene&acc=65268,,,65268.0,WNK2,9606,Homo sapiens (human),Gallic acid results in decreased expression of WNK2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
521,41913,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9913,Bos taurus (cattle),Gallic acid results in decreased activity of XDH protein,,,PMID:29071757,https://www.ncbi.nlm.nih.gov/pubmed/29071757,29071757,,
522,41914,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in increased activity of XDH protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
523,42116,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606,Homo sapiens (human),"Gallic acid inhibits the reaction [XDH protein alternative form results in increased reduction of bis(2,9-dimethyl-1,10-phenanthroline)copper(ii)]|gallic acid inhibits the reaction [XDH protein alternative form results in increased chemical synthesis of uric acid]",,,PMID:19231354,https://www.ncbi.nlm.nih.gov/pubmed/19231354,19231354,,
524,42117,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of XIAP mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
525,42118,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7511,XPNPEP1,https://ctdbase.org/detail.go?type=gene&acc=7511,,,7511.0,XPNPEP1,9606,Homo sapiens (human),Gallic acid results in increased expression of XPNPEP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
526,42119,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,9606,Homo sapiens (human),Gallic acid results in decreased expression of XRCC4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
527,42120,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54059,YBEY,https://ctdbase.org/detail.go?type=gene&acc=54059,,,54059.0,YBEY,9606,Homo sapiens (human),Gallic acid results in decreased expression of YBEY mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
528,42121,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,85463,ZC3H12C,https://ctdbase.org/detail.go?type=gene&acc=85463,,,85463.0,ZC3H12C,9606,Homo sapiens (human),Gallic acid results in increased expression of ZC3H12C mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
529,42122,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51530,ZC3HC1,https://ctdbase.org/detail.go?type=gene&acc=51530,,,51530.0,ZC3HC1,9606,Homo sapiens (human),Gallic acid results in increased expression of ZC3HC1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
530,42123,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22835,ZFP30,https://ctdbase.org/detail.go?type=gene&acc=22835,,,22835.0,ZFP30,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZFP30 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
531,42124,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,643836,ZFP62,https://ctdbase.org/detail.go?type=gene&acc=643836,,,643836.0,ZFP62,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZFP62 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
532,42125,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,118813,ZFYVE27,https://ctdbase.org/detail.go?type=gene&acc=118813,,,118813.0,ZFYVE27,9606,Homo sapiens (human),Gallic acid results in increased expression of ZFYVE27 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
533,42126,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7586,ZKSCAN1,https://ctdbase.org/detail.go?type=gene&acc=7586,,,7586.0,ZKSCAN1,9606,Homo sapiens (human),Gallic acid results in increased expression of ZKSCAN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
534,42315,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9203,ZMYM3,https://ctdbase.org/detail.go?type=gene&acc=9203,,,9203.0,ZMYM3,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZMYM3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
535,42316,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23613,ZMYND8,https://ctdbase.org/detail.go?type=gene&acc=23613,,,23613.0,ZMYND8,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZMYND8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
536,42317,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7748,ZNF195,https://ctdbase.org/detail.go?type=gene&acc=7748,,,7748.0,ZNF195,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF195 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
537,42318,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7755,ZNF205,https://ctdbase.org/detail.go?type=gene&acc=7755,,,7755.0,ZNF205,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF205 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
538,42319,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10520,ZNF211,https://ctdbase.org/detail.go?type=gene&acc=10520,,,10520.0,ZNF211,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF211 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
539,42320,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7571,ZNF23,https://ctdbase.org/detail.go?type=gene&acc=7571,,,7571.0,ZNF23,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF23 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
540,42321,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9534,ZNF254,https://ctdbase.org/detail.go?type=gene&acc=9534,,,9534.0,ZNF254,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF254 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
541,42322,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9422,ZNF264,https://ctdbase.org/detail.go?type=gene&acc=9422,,,9422.0,ZNF264,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF264 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
542,42323,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,57335,ZNF286A,https://ctdbase.org/detail.go?type=gene&acc=57335,,,57335.0,ZNF286A,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF286A mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
543,42324,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79673,ZNF329,https://ctdbase.org/detail.go?type=gene&acc=79673,,,79673.0,ZNF329,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF329 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
544,42325,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7592,ZNF41,https://ctdbase.org/detail.go?type=gene&acc=7592,,,7592.0,ZNF41,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF41 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
545,42522,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,170959,ZNF431,https://ctdbase.org/detail.go?type=gene&acc=170959,,,170959.0,ZNF431,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF431 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
546,42523,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,90333,ZNF468,https://ctdbase.org/detail.go?type=gene&acc=90333,,,90333.0,ZNF468,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF468 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
547,42524,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22869,ZNF510,https://ctdbase.org/detail.go?type=gene&acc=22869,,,22869.0,ZNF510,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF510 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
548,42525,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,162972,ZNF550,https://ctdbase.org/detail.go?type=gene&acc=162972,,,162972.0,ZNF550,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF550 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
549,42526,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,126231,ZNF573,https://ctdbase.org/detail.go?type=gene&acc=126231,,,126231.0,ZNF573,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF573 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
550,42527,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,58491,ZNF71,https://ctdbase.org/detail.go?type=gene&acc=58491,,,58491.0,ZNF71,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF71 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
551,42528,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,148206,ZNF714,https://ctdbase.org/detail.go?type=gene&acc=148206,,,148206.0,ZNF714,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF714 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
552,42529,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51333,ZNF771,https://ctdbase.org/detail.go?type=gene&acc=51333,,,51333.0,ZNF771,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF771 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
553,42530,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55565,ZNF821,https://ctdbase.org/detail.go?type=gene&acc=55565,,,55565.0,ZNF821,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF821 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
554,42531,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,152485,ZNF827,https://ctdbase.org/detail.go?type=gene&acc=152485,,,152485.0,ZNF827,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF827 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
555,42532,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55769,ZNF83,https://ctdbase.org/detail.go?type=gene&acc=55769,,,55769.0,ZNF83,9606,Homo sapiens (human),Gallic acid results in increased expression of ZNF83 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
556,42731,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,7637,ZNF84,https://ctdbase.org/detail.go?type=gene&acc=7637,,,7637.0,ZNF84,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNF84 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
557,42732,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,57169,ZNFX1,https://ctdbase.org/detail.go?type=gene&acc=57169,,,57169.0,ZNFX1,9606,Homo sapiens (human),Gallic acid results in decreased expression of ZNFX1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
558,44843,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,132949,AASDH,https://ctdbase.org/detail.go?type=gene&acc=132949,,,132949.0,AASDH,9606,Homo sapiens (human),Gallic acid results in increased expression of AASDH mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
559,44844,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,20,ABCA2,https://ctdbase.org/detail.go?type=gene&acc=20,,,20.0,ABCA2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ABCA2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
560,44845,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23461,ABCA5,https://ctdbase.org/detail.go?type=gene&acc=23461,,,23461.0,ABCA5,9606,Homo sapiens (human),Gallic acid results in decreased expression of ABCA5 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
561,44846,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),Gallic acid results in decreased expression of ABCB1 protein,,,PMID:20513373,https://www.ncbi.nlm.nih.gov/pubmed/20513373,20513373,,
562,44847,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83451,ABHD11,https://ctdbase.org/detail.go?type=gene&acc=83451,,,83451.0,ABHD11,9606,Homo sapiens (human),Gallic acid results in decreased expression of ABHD11 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
563,44848,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10006,ABI1,https://ctdbase.org/detail.go?type=gene&acc=10006,,,10006.0,ABI1,9606,Homo sapiens (human),Gallic acid results in decreased expression of ABI1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
564,44849,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,25,ABL1,https://ctdbase.org/detail.go?type=gene&acc=25,,,25.0,ABL1,9606,Homo sapiens (human),Gallic acid promotes the reaction [imatinib mesylate results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]|gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]|imatinib mesylate promotes the reaction [gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]],,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
565,44850,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,80724,ACAD10,https://ctdbase.org/detail.go?type=gene&acc=80724,,,80724.0,ACAD10,9606,Homo sapiens (human),Gallic acid results in decreased expression of ACAD10 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
566,44851,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,176,ACAN,https://ctdbase.org/detail.go?type=gene&acc=176,,,176.0,ACAN,9986,Oryctolagus cuniculus (rabbit),Gallic acid results in decreased expression of ACAN mRNA,,,PMID:25130855,https://www.ncbi.nlm.nih.gov/pubmed/25130855,25130855,,
567,45025,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,176,ACAN,https://ctdbase.org/detail.go?type=gene&acc=176,,,176.0,ACAN,10116,Rattus norvegicus (Norway rat),Gallic acid results in decreased expression of ACAN mRNA,,,PMID:26107568,https://www.ncbi.nlm.nih.gov/pubmed/26107568,26107568,,
568,45026,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,576,ADGRB2,https://ctdbase.org/detail.go?type=gene&acc=576,,,576.0,ADGRB2,9606,Homo sapiens (human),Gallic acid results in increased expression of ADGRB2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
569,45027,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10149,ADGRG2,https://ctdbase.org/detail.go?type=gene&acc=10149,,,10149.0,ADGRG2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ADGRG2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
570,45028,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,125061,AFMID,https://ctdbase.org/detail.go?type=gene&acc=125061,,,125061.0,AFMID,9606,Homo sapiens (human),Gallic acid results in decreased expression of AFMID mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
571,45029,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,116988,AGAP3,https://ctdbase.org/detail.go?type=gene&acc=116988,,,116988.0,AGAP3,9606,Homo sapiens (human),Gallic acid results in decreased expression of AGAP3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
572,45030,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,177,AGER,https://ctdbase.org/detail.go?type=gene&acc=177,,,177.0,AGER,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of AGER protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
573,45031,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11214,AKAP13,https://ctdbase.org/detail.go?type=gene&acc=11214,,,11214.0,AKAP13,9606,Homo sapiens (human),Gallic acid results in increased expression of AKAP13 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
574,45032,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
575,45033,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),AKT1 protein inhibits the reaction [gallic acid results in decreased expression of HIF1A mrna]|akt1 protein inhibits the reaction [gallic acid results in decreased expression of VEGFA mrna],,,PMID:26530725,https://www.ncbi.nlm.nih.gov/pubmed/26530725,26530725,,
576,45034,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]]|src protein modified form inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]]|[map2k1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [gallic acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]|gallic acid inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein],,,PMID:27087131,https://www.ncbi.nlm.nih.gov/pubmed/27087131,27087131,,
577,45227,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Gallic acid results in decreased activity of AKT1 protein,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
578,45228,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Gallic acid results in decreased phosphorylation of AKT1 protein,,,PMID:23153558|PMID:26530725,https://www.ncbi.nlm.nih.gov/pubmed/23153558|https://www.ncbi.nlm.nih.gov/pubmed/26530725,23153558|26530725,,
579,45229,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),RHOB mutant form inhibits the reaction [gallic acid results in decreased phosphorylation of AKT1 protein],,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
580,45230,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [lead results in decreased activity of ALAD protein],,,PMID:21402136,https://www.ncbi.nlm.nih.gov/pubmed/21402136,21402136,,
581,45231,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [ALB modified form results in increased expression of TIMP2 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP2 protein]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP2 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased expression of NCF1 protein]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP9 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased expression of AGER protein]|gallic acid inhibits the reaction [ALB modified form results in increased expression of MMP9 protein]|gallic acid inhibits the reaction [ALB modified form results in increased expression of TIMP1 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased expression of TNF protein]|gallic acid inhibits the reaction [ALB modified form results in decreased expression of TIMP3 mrna]|gallic acid inhibits the reaction [ALB modified form results in increased phosphorylation of MAPK1 protein]|gallic acid inhibits the reaction [ALB modified form results in increased phosphorylation of MAPK3 protein],,,PMID:24309158,https://www.ncbi.nlm.nih.gov/pubmed/24309158,24309158,,
582,45232,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [streptozocin results in decreased expression of ALB protein],,,PMID:29331653,https://www.ncbi.nlm.nih.gov/pubmed/29331653,29331653,,
583,45233,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,440138,ALG11,https://ctdbase.org/detail.go?type=gene&acc=440138,,,440138.0,ALG11,9606,Homo sapiens (human),Gallic acid results in decreased expression of ALG11 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
584,45234,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,121642,ALKBH2,https://ctdbase.org/detail.go?type=gene&acc=121642,,,121642.0,ALKBH2,9606,Homo sapiens (human),Gallic acid results in decreased activity of ALKBH2 protein,,,PMID:31088072,https://www.ncbi.nlm.nih.gov/pubmed/31088072,31088072,,
585,45235,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55626,AMBRA1,https://ctdbase.org/detail.go?type=gene&acc=55626,,,55626.0,AMBRA1,9606,Homo sapiens (human),Gallic acid results in increased expression of AMBRA1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
586,45434,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,83607,AMMECR1L,https://ctdbase.org/detail.go?type=gene&acc=83607,,,83607.0,AMMECR1L,9606,Homo sapiens (human),Gallic acid results in decreased expression of AMMECR1L mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
587,45435,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,196394,AMN1,https://ctdbase.org/detail.go?type=gene&acc=196394,,,196394.0,AMN1,9606,Homo sapiens (human),Gallic acid results in increased expression of AMN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
588,45436,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,51529,ANAPC11,https://ctdbase.org/detail.go?type=gene&acc=51529,,,51529.0,ANAPC11,9606,Homo sapiens (human),Gallic acid results in increased expression of ANAPC11 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
589,45437,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,29123,ANKRD11,https://ctdbase.org/detail.go?type=gene&acc=29123,,,29123.0,ANKRD11,9606,Homo sapiens (human),Gallic acid results in increased expression of ANKRD11 mrna|gallic acid results in decreased expression of ANKRD11 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
590,45438,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,338699,ANKRD42,https://ctdbase.org/detail.go?type=gene&acc=338699,,,338699.0,ANKRD42,9606,Homo sapiens (human),Gallic acid results in decreased expression of ANKRD42 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
591,45439,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ANXA2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
592,45440,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,164,AP1G1,https://ctdbase.org/detail.go?type=gene&acc=164,,,164.0,AP1G1,9606,Homo sapiens (human),Gallic acid results in increased expression of AP1G1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
593,45441,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,9606,Homo sapiens (human),Gallic acid results in increased expression of AP1M1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
594,45442,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8943,AP3D1,https://ctdbase.org/detail.go?type=gene&acc=8943,,,8943.0,AP3D1,9606,Homo sapiens (human),Gallic acid results in increased expression of AP3D1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
595,45443,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606,Homo sapiens (human),Gallic acid results in decreased secretion of APOB protein,,,PMID:12612140,https://www.ncbi.nlm.nih.gov/pubmed/12612140,12612140,,
596,45444,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),"Gallic acid inhibits the reaction [2,5-dihydroxybenzoic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]|gallic acid inhibits the reaction [2,3-dihydroxybenzoic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]|gallic acid inhibits the reaction [protocatechuic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]",,,PMID:22129351,https://www.ncbi.nlm.nih.gov/pubmed/22129351,22129351,,
597,45632,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,9606,Homo sapiens (human),Gallic acid results in decreased expression of AQP1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
598,45633,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10093,ARPC4,https://ctdbase.org/detail.go?type=gene&acc=10093,,,10093.0,ARPC4,9606,Homo sapiens (human),Gallic acid results in increased expression of ARPC4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
599,45634,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,64801,ARV1,https://ctdbase.org/detail.go?type=gene&acc=64801,,,64801.0,ARV1,9606,Homo sapiens (human),Gallic acid results in decreased expression of ARV1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
600,45635,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606,Homo sapiens (human),Gallic acid results in decreased expression of ASXL1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
601,45636,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,9776,ATG13,https://ctdbase.org/detail.go?type=gene&acc=9776,,,9776.0,ATG13,9606,Homo sapiens (human),Gallic acid results in increased expression of ATG13 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
602,45637,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606,Homo sapiens (human),Gallic acid results in decreased expression of ATM mRNA,,,PMID:21887735|PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/21887735|https://www.ncbi.nlm.nih.gov/pubmed/34408198,21887735|34408198,,
603,45638,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,490,ATP2B1,https://ctdbase.org/detail.go?type=gene&acc=490,,,490.0,ATP2B1,9606,Homo sapiens (human),Gallic acid results in increased expression of ATP2B1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
604,45639,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,155066,ATP6V0E2,https://ctdbase.org/detail.go?type=gene&acc=155066,,,155066.0,ATP6V0E2,9606,Homo sapiens (human),Gallic acid results in decreased expression of ATP6V0E2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
605,45640,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,545,ATR,https://ctdbase.org/detail.go?type=gene&acc=545,,,545.0,ATR,9606,Homo sapiens (human),Gallic acid results in decreased expression of ATR mRNA,,,PMID:21887735,https://www.ncbi.nlm.nih.gov/pubmed/21887735,21887735,,
606,45641,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6311,ATXN2,https://ctdbase.org/detail.go?type=gene&acc=6311,,,6311.0,ATXN2,9606,Homo sapiens (human),Gallic acid results in increased expression of ATXN2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
607,45642,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,26053,AUTS2,https://ctdbase.org/detail.go?type=gene&acc=26053,,,26053.0,AUTS2,9606,Homo sapiens (human),Gallic acid results in increased expression of AUTS2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
608,45837,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,9606,Homo sapiens (human),Gallic acid results in decreased expression of B2M mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
609,45838,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,126792,B3GALT6,https://ctdbase.org/detail.go?type=gene&acc=126792,,,126792.0,B3GALT6,9606,Homo sapiens (human),Gallic acid results in decreased expression of B3GALT6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
610,45839,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8702,B4GALT4,https://ctdbase.org/detail.go?type=gene&acc=8702,,,8702.0,B4GALT4,9606,Homo sapiens (human),Gallic acid results in decreased expression of B4GALT4 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
611,45840,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55024,BANK1,https://ctdbase.org/detail.go?type=gene&acc=55024,,,55024.0,BANK1,9606,Homo sapiens (human),Gallic acid results in increased expression of BANK1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
612,45841,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,580,BARD1,https://ctdbase.org/detail.go?type=gene&acc=580,,,580.0,BARD1,9606,Homo sapiens (human),Gallic acid results in decreased expression of BARD1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
613,45842,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[paclitaxel co-treated with gallic acid] results in increased expression of BAX mrna|[gallic acid co-treated with carboplatin] results in increased expression of BAX mrna|[paclitaxel co-treated with gallic acid] results in increased expression of BAX protein|[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of BAX protein|[carboplatin co-treated with gallic acid] results in increased expression of BAX protein|gallic acid results in increased expression of BAX mrna|[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of BAX mRNA,,,PMID:33002289,https://www.ncbi.nlm.nih.gov/pubmed/33002289,33002289,,
614,45843,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Gallic acid results in increased expression of BAX protein,,,PMID:22245431|PMID:33002289,https://www.ncbi.nlm.nih.gov/pubmed/22245431|https://www.ncbi.nlm.nih.gov/pubmed/33002289,22245431|33002289,,
615,45844,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of BAX protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
616,45845,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased expression of BCL2 mrna],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
617,45846,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Gallic acid results in decreased expression of BCL2 protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
618,46045,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in decreased expression of BCL2 protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
619,46046,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [gallic acid results in decreased expression of BCL2 protein]|gallic acid results in decreased expression of BCL2 protein,,,PMID:19723098,https://www.ncbi.nlm.nih.gov/pubmed/19723098,19723098,,
620,46047,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,10090,Mus musculus (house mouse),Gallic acid results in decreased expression of BCL2L11 mRNA,,,PMID:29205955,https://www.ncbi.nlm.nih.gov/pubmed/29205955,29205955,,
621,46048,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,613,BCR,https://ctdbase.org/detail.go?type=gene&acc=613,,,613.0,BCR,9606,Homo sapiens (human),Gallic acid promotes the reaction [imatinib mesylate results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]|gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]|imatinib mesylate promotes the reaction [gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]],,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
622,46049,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,622,BDH1,https://ctdbase.org/detail.go?type=gene&acc=622,,,622.0,BDH1,9606,Homo sapiens (human),Gallic acid results in increased expression of BDH1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
623,46050,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
624,46051,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),Gallic acid results in increased expression of BDNF mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
625,46052,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,329,BIRC2,https://ctdbase.org/detail.go?type=gene&acc=329,,,329.0,BIRC2,9606,Homo sapiens (human),Gallic acid results in decreased expression of BIRC2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
626,46053,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Gallic acid results in increased expression of CASP3 mrna|[paclitaxel co-treated with gallic acid] results in increased expression of CASP3 protein|[paclitaxel co-treated with gallic acid] results in increased expression of CASP3 mrna|[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of CASP3 mrna|[gallic acid co-treated with carboplatin] results in increased expression of CASP3 mrna|[carboplatin co-treated with gallic acid] results in increased expression of CASP3 protein|[paclitaxel co-treated with carboplatin co-treated with gallic acid] results in increased expression of CASP3 protein,,,PMID:33002289,https://www.ncbi.nlm.nih.gov/pubmed/33002289,33002289,,
627,46243,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Gallic acid results in increased activity of CASP3 protein,,,PMID:24726691|PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/24726691|https://www.ncbi.nlm.nih.gov/pubmed/34408198,24726691|34408198,,
628,46244,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Gallic acid results in increased expression of CASP3 protein,,,PMID:22245431|PMID:33002289,https://www.ncbi.nlm.nih.gov/pubmed/22245431|https://www.ncbi.nlm.nih.gov/pubmed/33002289,22245431|33002289,,
629,46245,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [doxorubicin results in increased cleavage of CASP3 protein],,,PMID:36572231,https://www.ncbi.nlm.nih.gov/pubmed/36572231,36572231,,
630,46246,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Gallic acid results in decreased expression of CASP3 mRNA,,,PMID:29205955,https://www.ncbi.nlm.nih.gov/pubmed/29205955,29205955,,
631,46247,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of CASP3 protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
632,46248,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [quinolinic acid results in increased activity of CASP3 protein],,,PMID:29981346,https://www.ncbi.nlm.nih.gov/pubmed/29981346,29981346,,
633,46249,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),Gallic acid results in decreased expression of CASP7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
634,46250,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),Gallic acid results in increased activity of CASP7 protein,,,PMID:24726691,https://www.ncbi.nlm.nih.gov/pubmed/24726691,24726691,,
635,46251,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Gallic acid results in increased expression of CASP8 protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
636,46252,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406,BMAL1,https://ctdbase.org/detail.go?type=gene&acc=406,,,406.0,BMAL1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BNIP3 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX6C mrna]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX2 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of BMAL1 mrna]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of CREB1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of DNM1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of COX4 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of FIS1 protein]]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of HMOX1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of BMAL1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BDNF protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
637,46653,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,406,BMAL1,https://ctdbase.org/detail.go?type=gene&acc=406,,,406.0,BMAL1,9606,Homo sapiens (human),Gallic acid results in increased expression of BMAL1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
638,46654,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,55589,BMP2K,https://ctdbase.org/detail.go?type=gene&acc=55589,,,55589.0,BMP2K,9606,Homo sapiens (human),Gallic acid results in increased expression of BMP2K mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
639,46655,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,664,BNIP3,https://ctdbase.org/detail.go?type=gene&acc=664,,,664.0,BNIP3,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BNIP3 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of BNIP3 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
640,46656,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,79184,BRCC3,https://ctdbase.org/detail.go?type=gene&acc=79184,,,79184.0,BRCC3,9606,Homo sapiens (human),Gallic acid results in decreased expression of BRCC3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
641,46657,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22903,BTBD3,https://ctdbase.org/detail.go?type=gene&acc=22903,,,22903.0,BTBD3,9606,Homo sapiens (human),Gallic acid results in decreased expression of BTBD3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
642,46658,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,54058,C21ORF58,https://ctdbase.org/detail.go?type=gene&acc=54058,,,54058.0,C21orf58,9606,Homo sapiens (human),Gallic acid results in decreased expression of C21ORF58 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
643,46659,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,84281,C2ORF88,https://ctdbase.org/detail.go?type=gene&acc=84281,,,84281.0,C2orf88,9606,Homo sapiens (human),Gallic acid results in increased expression of C2ORF88 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
644,46660,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,203228,C9ORF72,https://ctdbase.org/detail.go?type=gene&acc=203228,,,203228.0,C9orf72,9606,Homo sapiens (human),Gallic acid results in decreased expression of C9ORF72 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
645,46661,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,11094,CACFD1,https://ctdbase.org/detail.go?type=gene&acc=11094,,,11094.0,CACFD1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CACFD1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
646,46662,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,10241,CALCOCO2,https://ctdbase.org/detail.go?type=gene&acc=10241,,,10241.0,CALCOCO2,9606,Homo sapiens (human),Gallic acid results in increased expression of CALCOCO2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
647,46861,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,818,CAMK2G,https://ctdbase.org/detail.go?type=gene&acc=818,,,818.0,CAMK2G,9606,Homo sapiens (human),Gallic acid results in increased expression of CAMK2G mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
648,46862,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,23271,CAMSAP2,https://ctdbase.org/detail.go?type=gene&acc=23271,,,23271.0,CAMSAP2,9606,Homo sapiens (human),Gallic acid results in increased expression of CAMSAP2 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
649,46863,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,823,CAPN1,https://ctdbase.org/detail.go?type=gene&acc=823,,,823.0,CAPN1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CAPN1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
650,46864,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,826,CAPNS1,https://ctdbase.org/detail.go?type=gene&acc=826,,,826.0,CAPNS1,9606,Homo sapiens (human),Gallic acid results in increased expression of CAPNS1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
651,46865,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,8573,CASK,https://ctdbase.org/detail.go?type=gene&acc=8573,,,8573.0,CASK,9606,Homo sapiens (human),Gallic acid results in decreased expression of CASK mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
652,46866,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),"Gallic acid results in increased cleavage of CASP3 protein|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [gallic acid results in increased cleavage of CASP3 protein]",,,PMID:27060209,https://www.ncbi.nlm.nih.gov/pubmed/27060209,27060209,,
653,46867,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),"Gallic acid results in increased cleavage of CASP9 protein|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [gallic acid results in increased cleavage of CASP9 protein]",,,PMID:27060209,https://www.ncbi.nlm.nih.gov/pubmed/27060209,27060209,,
654,46868,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,831,CAST,https://ctdbase.org/detail.go?type=gene&acc=831,,,831.0,CAST,9606,Homo sapiens (human),Gallic acid results in decreased expression of CAST mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
655,46869,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [diethylhexyl phthalate results in decreased activity of CAT protein],,,PMID:35196152,https://www.ncbi.nlm.nih.gov/pubmed/35196152,35196152,,
656,46870,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Gallic acid results in increased activity of CAT protein,,,PMID:29205955,https://www.ncbi.nlm.nih.gov/pubmed/29205955,29205955,,
657,47036,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),"Gallic acid inhibits the reaction [1,2-dimethylhydrazine results in decreased activity of CAT protein]",,,PMID:31925992,https://www.ncbi.nlm.nih.gov/pubmed/31925992,31925992,,
658,47037,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [isoproterenol results in decreased expression of CAT protein],,,PMID:19146839,https://www.ncbi.nlm.nih.gov/pubmed/19146839,19146839,,
659,47038,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased activity of CAT protein],,,PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/26341651,26341651,,
660,47039,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [streptozocin results in decreased activity of CAT protein],,,PMID:29331653,https://www.ncbi.nlm.nih.gov/pubmed/29331653,29331653,,
661,47040,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [thioacetamide results in decreased activity of CAT protein],,,PMID:32278740,https://www.ncbi.nlm.nih.gov/pubmed/32278740,32278740,,
662,47041,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [zearalenone results in decreased activity of CAT protein],,,PMID:34723416,https://www.ncbi.nlm.nih.gov/pubmed/34723416,34723416,,
663,47042,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein inhibits the reaction [gallic acid results in increased activity of MGST1 protein],,,PMID:16125204,https://www.ncbi.nlm.nih.gov/pubmed/16125204,16125204,,
664,47043,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,875,CBS,https://ctdbase.org/detail.go?type=gene&acc=875,,,875.0,CBS,9606,Homo sapiens (human),Gallic acid results in decreased expression of CBS mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
665,47044,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,150275,CCDC117,https://ctdbase.org/detail.go?type=gene&acc=150275,,,150275.0,CCDC117,9606,Homo sapiens (human),Gallic acid results in increased expression of CCDC117 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
666,47045,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,886,CCKAR,https://ctdbase.org/detail.go?type=gene&acc=886,,,886.0,CCKAR,10116,Rattus norvegicus (Norway rat),Gallic acid inhibits the reaction [8-sulfocholecystokinin octapeptide results in increased activity of CCKAR protein],,,PMID:24630973,https://www.ncbi.nlm.nih.gov/pubmed/24630973,24630973,,
667,47254,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),Gallic acid inhibits the reaction [lipopolysaccharides results in increased secretion of CCL2 protein],,,PMID:31306686,https://www.ncbi.nlm.nih.gov/pubmed/31306686,31306686,,
668,47255,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Gallic acid analog inhibits the reaction [indomethacin results in increased expression of CCL2 mrna],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
669,47256,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CCNE1 protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
670,47257,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,126731,CCSAP,https://ctdbase.org/detail.go?type=gene&acc=126731,,,126731.0,CCSAP,9606,Homo sapiens (human),Gallic acid results in decreased expression of CCSAP mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
671,47258,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,966,CD59,https://ctdbase.org/detail.go?type=gene&acc=966,,,966.0,CD59,9606,Homo sapiens (human),Gallic acid results in decreased expression of CD59 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
672,47259,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,998,CDC42,https://ctdbase.org/detail.go?type=gene&acc=998,,,998.0,CDC42,9606,Homo sapiens (human),Gallic acid results in decreased expression of CDC42 protein,,,PMID:23153558,https://www.ncbi.nlm.nih.gov/pubmed/23153558,23153558,,
673,47260,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1022,CDK7,https://ctdbase.org/detail.go?type=gene&acc=1022,,,1022.0,CDK7,9606,Homo sapiens (human),Gallic acid results in decreased expression of CDK7 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
674,47261,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Gallic acid results in increased expression of CDKN1A protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
675,47262,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606,Homo sapiens (human),Gallic acid results in increased expression of CDKN1B protein,,,PMID:22245431,https://www.ncbi.nlm.nih.gov/pubmed/22245431,22245431,,
676,47263,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1033,CDKN3,https://ctdbase.org/detail.go?type=gene&acc=1033,,,1033.0,CDKN3,9606,Homo sapiens (human),Gallic acid results in decreased expression of CDKN3 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
677,47264,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10090,Mus musculus (house mouse),Gallic acid results in decreased expression of CEBPB protein,,,PMID:24036142,https://www.ncbi.nlm.nih.gov/pubmed/24036142,24036142,,
678,47455,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,22832,CEP162,https://ctdbase.org/detail.go?type=gene&acc=22832,,,22832.0,CEP162,9606,Homo sapiens (human),Gallic acid results in decreased expression of CEP162 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
679,47456,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,285753,CEP57L1,https://ctdbase.org/detail.go?type=gene&acc=285753,,,285753.0,CEP57L1,9606,Homo sapiens (human),Gallic acid results in decreased expression of CEP57L1 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
680,47457,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,253782,CERS6,https://ctdbase.org/detail.go?type=gene&acc=253782,,,253782.0,CERS6,9606,Homo sapiens (human),Gallic acid results in decreased expression of CERS6 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
681,47458,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,64377,CHST8,https://ctdbase.org/detail.go?type=gene&acc=64377,,,64377.0,CHST8,9606,Homo sapiens (human),Gallic acid results in decreased expression of CHST8 mRNA,,,PMID:34408198,https://www.ncbi.nlm.nih.gov/pubmed/34408198,34408198,,
682,47459,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147.0,CHUK,9606,Homo sapiens (human),Gallic acid inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein],,,PMID:21420233,https://www.ncbi.nlm.nih.gov/pubmed/21420233,21420233,,
683,47460,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147.0,CHUK,9606,Homo sapiens (human),Gallic acid results in decreased activity of CHUK protein,,,PMID:22387266,https://www.ncbi.nlm.nih.gov/pubmed/22387266,22387266,,
684,82975,370,BindingDB,Gallic Acid,50085536,"3,4,5-Trihydroxybenzoate, X",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085536,5270,Prolyl 4-hydroxylase subunit alpha-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5270,P16924,Prolyl 4-hydroxylase subunit alpha-1,,,9031,Gallus gallus (chicken),,Ki (nM),30000,PMID:3011801,https://www.ncbi.nlm.nih.gov/pubmed/3011801,3011801,,
